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The aim of this thesis was to investigate the in vitro physiological and genetic 
responses of Bacillus cereus ATCC 14579 to bile, bile salts and mucin, substances 
which would be encountered in the gastrointestinal tract. 
 
B. cereus was grown in media containing bile/bile salts and growth only occurred at 
low concentrations (no growth observed on LB-agar plates with 0.02 % bile salts). 
Preincubation with bile salts at non-lethal concentrations did not increase the levels of 
bile salts tolerance.  
 
Cultures of B. cereus were grown to the mid-exponential growth phase and shifted to 
media containing bile (0.03 %), bile salts (0.005 %) and mucin (0.25 %). Global 
expression patterns (shifts to bile and bile salts containing media) were determined by 
hybridization of total RNA to microarrays. The expression of selected genes, 
fibronectin binding protein and two internalin genes, in shift experiments to bile, bile 
salts and mucin containing media were investigated by RT-PCR. The microarray data 
indicated a general stress response to bile and bile salts. The RT-PCR indicated a 
down-regulation of a putative virulence factor, internalin, in bile salts cultures. 
 
Proteins were extracted from the shift experiments (not mucin) 30 minutes after the 
shift in a LiCl-buffer and analyzed by 2-D protein electrophoresis. Protein spots 
showing differential expression were excised, trypsin digested and analysed by 
MALDI-TOF. Protein identification by protein mass fingerprinting showed that 
dihydrolipoamide dehydrogenase was up-regulated in both shift experimets. Enolase 
was up-regulated in bile cultures, but down-regulated in bile salts cultures 
 
All off the findings in this study indicate that B. cereus ATCC 14579 vegetative cells 
would not survive in the intestinal environment. Down-regulation of virulence factors 
and induction of what seem to be a secondary stress response indicates that B. cereus 
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1.1 Bacillus cereus 
1.1 Bacillus cereus 
1.1.1 The Bacillus genus 
The bacillus genus is a diverse group of gram positive endospore-forming rod shaped 
bacteria. They are aerobic or facultative anaerobic and found ubiquitously in the 
environment  commonly isolated from soil, water, dust and air (Reviewed by 
Drobniewski, 1993). The vegetative cells range from approximately 0.5 by 1.2 to 2.5 
by 10 µm in length and most Bacillus species grow optimally at temperatures from 25 
°C to 37 °C. Several thermophilic and psychrophilic species exists which can grow at 
temperature up to 75 °C and down to 3 °C (Drobniewski, 1993). Many bacilli produce 
extracellular hydrolytic enzymes capable of breaking down polymers such as 
polysaccharides, proteins or peptides and nucleic acids permitting the bacteria to use 
the monomers/oligomers as carbons sources and electron donors (Maidgan, 2003). 
Some species in the bacilli genus are responsible for the production of several 
antibiotics, such as bacitracin, polymyxin and cirulin. (Maidgan, 2003) Traditionally 
they are classified as low GC gram positive bacteria, however their GC level range 
from 32 % to 69 %. (Drobniewski, 1993; Maidgan, 2003) 
 
1.1.2 The Bacillus cereus group 
The Bacillus cereus group (or Bacillus cereus sensu latu) contains Bacillus cereus, 
Bacillus anthracis, Bacillus thuringiensis, Bacillus weihenstephanensis, Bacillus 
mycoides and Bacillus pseudomycoides (Drobniewski, 1993; Lechner et al., 1998; 
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Nakamura, 1998). These six species are phenotypically and genetically closely 
related, but with regard to pathogenicity they differ; Bacillus cereus – food poisoning, 
systemic infections, Bacillus thuringiensis – insect pathogen and Bacillus anthracis – 
the causative agent of anthrax.  
 
Bacillus thuringiensis has the ability to produce insecticidal crystal toxins with 
different specificity towards different insect larvae (lepidoptera, choleoptera, diptera) 
inside the bacteria cell during sporulation (reviewed by Schnepf et al., 1998). When 
insect larvae ingest spores and their inclusion bodies  the spores gain access to 
haemolymph, a source of nutrients suitable for germination and growth, resulting in 
the death of the larvae (Aronson, 1993). The crystal toxin genes (cry) are most 
frequently encoded on extracromosal plasmids (Gonzalez & Carlton, 1984; Sekar & 
Carlton, 1985). The insecticidal property has made Bacillus thuringiensis the most 
widely used biopesticide in the world, it has been in use for several decades (Hofte & 
Whiteley, 1989) and is therefore of immense value to the agricultural industry.  
 
Bacillus anthracis is widely known as the causative agent of the potentially lethal 
disease anthrax.  It is described as non-haemolytic, encapsulated and non-motile, 
(Reviewed by Mock & Fouet, 2001). The most lethal form of anthrax is caused by the 
inhalation of spores, which are taken up by alveolar macrophages. The spores are 
transported to lymph nodes where germination occurs. The bacteria then replicates to 
high numbers in the blood, ultimately leading to the death of the host (Reviewed by 
Abrami et al., 2005). The genes encoding the lethal effect are located on two 
plasmids: The anthrax toxin subunits (lethal factor, LF; edema factor, EF and 
protective antigen, PA) are located on a plasmid; pXO1. The genes (capBCAD) 
encoding the poly-D-glutamate capsule, in which also are implicated in virulence, is 
located on pXO2 (reviewed by Abrami et al., 2005). The capsule is not necessary for 
uptake to macrophages, however ΔcapBCAD mutants are highly attenuated for 
inhalation anthrax (Drysdale et al., 2005). 
 
Bacillus mycoides is easily distinguished from the other members of the Bacillus 
cereus group by its rhizoid colony shape made by curving filaments of bacteria cells 
and its lack of motility (Priest, 1993). Bacillus pseudomycoides resembles Bacillus 
mycoides, but lack the long filaments of bacteria cells, hence the name pseudes; false, 
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and mycoides; fungus-like. It is distinguished from Bacillus mycoides and Bacillus 
cereus by differences in  cell membrane fatty acid composition. Bacillus 
pseudomycoides was recognized as a species in 1998, and phylogenetically positioned 
as a member of the Bacillus cereus group (Nakamura, 1998).  
 
Bacillus weihenstephanensis is distinguished from Bacillus cereus by its 
psychrophilic abilities. It is capable of growth below 7 °C, but not at 43 °C. The DNA 
sequence show high similarity to B. cereus, but have differences, especially in cold 
shock genes. Bacillus weihenstephanensis was recognized as a species of the Bacillus 
cereus group in 1998 (Lechner et al., 1998). It is not known whether it is capable of 
causing food poisoning like Bacillus cereus, but in (2002) Stenfors, Mayr et al. 
indicated that many B. weihenstephanensis strains have the genetic makeup for 
producing essential pathogenicity factors, and that some do so under laboratory 
conditions. However, not all psychrotolerant strains of the B. cereus group are 
necessary B. weihenstephanensis (Stenfors & Granum, 2001) 
 
The close relationship between members of the Bacillus cereus group has been 
investigated by different molecular methods: (1) rRNA studies (Ash et al., 1991; Ash 
& Collins, 1992; Bavykin et al., 2004), (2) multilocus enzyme electrophoresis 
(Carlson et al., 1994; Helgason et al., 2000), (3) multilocus sequence typing 
(Helgason et al., 2004; Ko et al., 2004; Priest et al., 2004) and (4) rep-PCR 
fingerprinting (Cherif et al., 2003). The consensus of this work seem to be that the 
species in the Bacillus cereus group are so closely related that they all belong to the 
same species. It also seems that it is rather the plasmid they harbor, than the 
chromosome, which contributes to the pathogenic specificity. Therefore, strains of 
Bacillus anthracis that have lost their plasmids have been isolated and characterized 
as Bacillus cereus (Turnbull et al., 1992). Similarly Bacillus cereus strains that 
receive plasmid(s) encoding crystal toxins (from thuringiensis) or capsule formation 
(from anthracis) would be identified as Bacillus thuringiensis (Gonzalez et al., 1982) 
or Bacillus anthracis (Green et al., 1985), respectively. Bacteria of the Bacillus cereus 
group do have the ability to take up the pBtoxis plasmid of Bacillus thuringiensis by 
conjugation (Hu et al., 2005) and transformation (Gonzalez et al., 1982), and that 




The species status of the members of the Bacillus cereus group is therefore 
questionable. Ash, Farrow et al. (1991), Helgason, Okstad et al. (2000) and Kolsto, 
Lereclus et al. (2002) have proposed that members of the Bacillus cereus group 
should be considered belonging to the same species, and the different strains should 
be classified as variants of Bacillus cereus (e.g. Bacillus cereus var. anthracis.)  
 
1.1.3 Bacillus cereus 
Bacillus cereus is a motile, endospore forming, aerobe or facultative anaerobe gram 
positive bacterium that occurs ubiquitously in soil and in many raw processed foods 
such as rice, milk and diary products, vegetables and spices (Choma et al., 2000; 
Christiansson et al., 1999; Guinebretiere et al., 2003). The spores of Bacillus cereus 
can tolerate harsh physical and chemical conditions, and will also survive 
pasteurization. Consequently they will germinate in processed foods when 
temperature and other conditions are desirable for vegetative growth, and competitive 
flora is absent.  
 
To date four genomes of B. cereus strains are fully sequenced; ATCC 14579, ATCC 
10987, E33L (ZK), and G9241 (Brettin et al., 2005; Ivanova et al., 2003; Rasko et al., 
2004). The latter is available in contigs at NCBI. B. cereus G9241 is known for 
causing anthrax-like disease (Rasko et al., 2005). December this year the fifth 
genome, Bacillus cereus NVH391-98, was published as a draft sequence by the Doe 
Joint Genome Institute (USA). This strain was involved in a serious food poison 
outbreak in France 1998 (Lund et al., 2000). The sequenced genome consists of 
approximately 5.5 Mb, and ~5000 protein coding sequences. Sequence  comparisons 
with B. subtilis and other B. cereus group members reveals that while B. subtils has 
many enzymes for degradation of polysaccharides, members of the B. cereus group 
have fewer enzymes for polysaccharide degradation, but are well equipped with 
enzymes for degradation of polypeptides and proteins (Anderson et al., 2005; Ivanova 
et al., 2003; Rasko et al., 2004; Rasko et al., 2005). It was therefore proposed by 
Jensen et al. (2003) that all species in the B. cereus group are most likely symbionts 
or parasites of animals hosts rather than strict soil bacteria. This is recognized by 
comparisons of B. cereus group extracellular proteomes which reveals that many of 




Bacillus cereus has many extracellular proteins putatively involved in pathogenesis. 
Many of these are under control of the pleiotropic regulator plcR (Agaisse et al., 
1999; Salamitou et al., 2000) and includes proteins like collagenases, phospholipases, 
haemolysins, proteases and enterotoxins (Gohar et al., 2002). Genome analysis has 
indicated that the plcR-regulon may be involved in the regulation of  4 other 
transcription factors, metabolic enzymes, motility, sporulation, surface proteins, 
capsule formation and more (Ivanova et al., 2003). In vitro plcR reaches expression 
maximum at the beginning of the stationary phase, and is regulated in a quorum 
sensing manner (Slamti & Lereclus, 2002). Except for the emetic and entereo-toxins, 
it is not known how these degradative enzymes are implicated in pathogenesis, or 
what types of injury they can inflict or cause, in man or insects.  
 
Bacillus cereus is a commensialist/parasite of insects and an opportunistic pathogen, 
capable of causing several infections, in man. Infections caused by Bacillus cereus 
have been recorded since the beginning of the last century, and fall mainly into six 
categories (reviewed by Drobniewski, 1993): (1) local infections, particularly in sites 
of burns, injures, or the eye; (2) bacteremea and septicaemia; (3) infections of the 
central nervous system; (4) respiratory infections; (5) endocarditis and pericarditis; 
and (6) two kind of food poisoning syndromes. Usually infections occur in immuno-
compromised persons, after traumatic injury like penetration wounds or burns sites, or 
in neonates (Reviewed by Drobniewski, 1993; and Kotiranta et al., 2000) Bacillus 
cereus is the second most frequent cause of keratitis (Drobniewski, 1993) and 
Bacillus cereus eye infections are often severe and in a number of cases leads to 
blindness, (reviewed by Hemady et al., 1990). 
 
However, Bacillus cereus is most known for its food poisoning abilities. Generally it 
causes one of two types of syndromes; (1) nausea and vomiting, caused by an emetic 
toxin; or (2) diarrhea caused by at least one of three enterotoxins. Both types of 
syndromes are usually mild and last for less than 24 hours. Consequently food 
poisoning caused by Bacillus cereus is underreported (Granum & Lund, 1997). Some 
strains, however, cause rather severe infections and can in the worst case have fatal 
outcome. In France 1998 an outbreak of the diarrheal type led to the death of three 
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persons (Lund et al., 2000), and in 2004 a young girl died after infection with an 
emetic strain (Dierick et al., 2005).    
 
The emetic syndrome is caused by a heat- acid- and protease stable emetic toxin that 
is produced in the food, named cereulide. The toxin does not lose activity after 
treatment by heat (126 °C, 90 min), cold (4 °C, 2 months), extreme pH (pH 2 and 11, 
90 min) or by proteases (trypsin and pepsin) (Melling & Capel, 1978). Ingestion of 
living bacteria is therefore not necessary for symptoms, which usually last for 1 to 5 
hours (Mortimer & McCann, 1974). The cereulide is a cyclic dodecadepsipeptide that 
consists of a 36-memberd ring with ester and amide bonds one after each other which 
is non-ribosomally synthesized (Agata et al., 1994). It functions as K+-specific 
ionophore that induces swelling of mitochondira in livercells, and thereby inducing 
cell death in the liver and vomiting (Agata et al., 1995; Mikkola et al., 1999). The 
genetic determinants of cereulide has recently been documented to be located on a 
plasmid (Hoton et al., 2005) 
 
The symptoms of the diarrheal type of food-poisoning is described as abdominal pain, 
cramps and watery diarrhea and are usually experienced 8 – 16 hours after ingestion 
of contaminated food and usually lasts for 12 – 24 hours (Granum, 1994) The 
symptoms are caused by at least one of two enterotoxins; HBL, hemolysin BL and/or 
NHE, non-hemolytic enterotoxin (Granum et al., 1993; Lund & Granum, 1996; Lund 
& Granum, 1997). In addition a third toxin, cyt K, that was involved in a more severe 
case of food-poisoning causing necrotic enteritis has been described (Hardy et al., 
2001; Lund et al., 2000). All these enterotoxins are regulated by the plcR-regulon 
(Gohar et al., 2002). The enterotoxins are heat-liable and production of toxins in the 
small intestine is necessary for causing symptoms (Granum, 1994; Lund & Granum, 
1997).  
 
Except for the emetic- and enterotoxins, the molecular mechanism of pathogenesis in 
these infections is poorly understood. Little is also known of the ability of B. cereus to 
survive and eventually colonize the intestine. B. cereus is present and asymptotic in 
faeces of 14 % to 43 % of investigated individuals (Ghosh, 1978; Turnbull & Kramer, 
1985), which implies an ability to colonize the GI-tract, but it is not known whether 
these bacteria are probiotic or just “passing through”. To the best of my knowledge 
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very little is known about the genetic mechanisms for colonization of B. cereus in the 
GI-tract.  
 
Bacillus cereus ATCC 14579 is the reference (type) strain of Bacilus cereus. It is an 
environmental isolate and harbors the three enterotoxins, but not the emetic toxin 
(Ivanova et al., 2003). 
 
1.2 The Gastrointestinal tract 
1.2.1 The human gastrointestinal tract 
When food and bacteria are ingested they enter the oral cavity and reach GI-tract 
where the oral cavity ends. The first part, the esophagus, reaches from the oral cavity 
to the stomach. The food and bacteria enter the stomach and are subjected to low pH 
(~2) and digestive enzymes and muscle contractions. As foods leave the stomach it 
enters the small intestine, which is divided in three sections; the duodenum, jejunum 
and ileum. Bile and pancreatic enzymes are secreted into the duodenum and most of 
the digestion occurs in the small intestine. When digested foods leave the small 
intestine they enter the large intestine where water and electrolytes are re-absorbed.  
 
Mucus 
The inner layer of GI-tract is covered with mucus which acts as a lubricant for foods 
and as a protective barrier between the endothelial cells and the environment. In 
addition constitutes an important part of the non-specific defence system where it 
functions as a trap/barrier for particles and microorganisms. The mucus layer contains 
mostly glycoproteins and proteoglycans, in which various types of mucin are the 
major components. Mucin is a glycoprotein that contains over 80 % carbohydrate and 
is present both in soluble form in the outer level, and strongly attached to the 
endothelial cells (Feldman et al., 1998). In addition lipids, proteins and nucleic acids 
are also found in the mucus-layer (Reviewed by Allen et al., 1993). The composition 
and abundance of the mucus is subjected to variation in all parts of the GI-tract, but it 
makes 200 to 600 µm thick continuous gel throughout the GI-tract. (Allen et al., 




On the other side of the endothelial cells is the basal lamina which is a wide layer of 
extracellular matrix. The basal lamina consists of fibrous proteins such as collagen, 
fibronectin, laminin and elastin (Alberts et al., 2002). 
 
Bile  
Bile acid and bile salt are generally synonymous terms; bile acid refers to the 
molecule as acid, e. g. cholic acid, and bile salt refer to the salt of the same molecule, 
e. g. natrium-cholate. In this thesis the terms bile acids and bile salts are used 
interchangeably.  
 
Bile is a yellow/green aqueous solution that is secreted into the upper duodenum from 
the bile duct. It is synthesized in the liver, and partially stored and concentrated in the 
gallbladder. Its major organic constituents are bile acids (salts) cholesterols, 
phospholipids and the pigment biliverdin (Dawson, 1998). In addition is 
immunoglobin A and mucus secreted into the bile (Hofmann, 1999). Inorganic ions 
such as Na+, Cl-, and K+ are also found and the osmolarity is generally isotonic with 
plasma (Erlinger, 1994) . A section of the constituents and properties of bile is listed 
in table 1.1. The concentration of bile acids (salts) can be up to 8 % in the gallbladder 
and ranging from 0.2 % to 2 % in the small intestine (Dawson, 1998). 
Table 1.1 Major constituents and properties of human hepatic bile. Data collected from (Erlinger, 1994)   
Constituent/property  
Sodium (mmol/l) ~145 
Potassium (mmol/l) ~5 
Chloride (mmol/l) ~110 
Bile salts (mmol/l) 3 - 45 
Cholesterol (mmol/l) 2 - 8 
Phospholipids (mmol/l) 0.3 - 11 
pH  7.5–8.0 
Osmolarity (mOsm/kg) ~300 
 
 
There are a number of different bile acids, but the most abundant are; cholic acid, 
deoxycolic acid, chenodeoxycholic acid and lithocolic acid, which constitute 
approximately 95 % of the bile acids in human bile (Carey & Duane, 1994). Both 
cholic acid and chenodeoxycholic acid are conjugated to either glycine or taurine by 
peptide bonds before secretion. The intestinal flora modify these bile acids by 
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cleaveage of the peptide bond to form unconjugated bile acids (Carey & Duane, 1994) 
These reactions are usually carried out by bacterial enzymes called bile salt 
hydrolases (Christiaens et al., 1992; Desmet et al., 1995; Grill et al., 1995). 7α-
dehydroxyalation which converts cholic acid to deoxycholic acid and 
chenodeoxycholic acid to lithocholic acid is also a process performed by the 
microflora in the intestine and seems to be limited to anaerobic bacteria such as 
Eubacterium and Clostridium (Doerner et al., 1997; Wells & Hylemon, 2000) The 










































Figure 1.1 A) Modifications of bile acids by bacteria. Bile acids are conjugated with different amino 
acids by peptide bonds. Glycin conjugated cholic acid is cleaved to cholic acid and glycine by bile salt 
hydrolases. Cholic acid can again be modified by 7α-dehydroxylation to form deoxycholic acid. B) 
Taurine; bile acids can also be conjugated with taurine. C) Two other common bile acids; 
chenodeoxycholic acid and its dehydroxylated derivate; lithocholic acid. 
 
The major function of bile is the solubilisation and emulsification fats. This also 
makes bile a potent antimicrobial agent and it has an important role in the innate 
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immune-system. The detergent properties of bile are mostly due to bile acids (salts) 
which make up approximately 67 % (v/v) of bile from healthy humans (Carey & 
Duane, 1994). Although it is the detergent property that has most destructive effect on 
bacterial membranes, bile acids can also harm bacteria in other ways: Bile salts may 
induce secondary structure in RNA and induce DNA damage (Kandell & Bernstein, 
1991; Payne et al., 1998; Powell et al., 2001; Zheng & Bernstein, 1992). The 
detergent actions of bile salts may also lead to misfolding of proteins and the 
induction of chaperone genes as a response to bile acids, observed in many bacteria, is 
strong indicator to that denaturation may occur (Flahaut et al., 1996; Leverrier et al., 
2003; Schmidt & Zink, 2000). Bile may cause oxidative stress through the generation 
of free radicals (Lechner et al., 2002; Sokol et al., 1995) and in addition bile acid may 
chelate calsium and iron (Rajagopalan & Lindenbaum, 1982; Sanyal et al., 1991) 
 
1.2.2 Bacteria in the gastrointestinal tract 
Bile tolerance 
Some bacteria can tolerate very high levels of bile, e.g Salmonella typhimurium and 
E. coli have the ability to colonize the gallbladder (Prouty et al., 2002a), and E. coli, 
Camplyobacter spp., Streptococcus spp. and Clostridium spp. has been isolated 
directly from bile (Brook, 1989; Flores et al., 2003). Salmonella typhimurium has the 
ability to survive prolonged incubation in 60 % bile (oxbile) in vitro (Van 
Velkinburgh & Gunn, 1999). Other entero-pathogeneic bacteria also have a rather 
high tolerance to bile; e.g. Salmonella typhi tolerate 12 % oxbile in the growth media 
(Van Velkinburgh & Gunn, 1999) and Listeria monocytogenes survives in broth 
supplemented with 15 % human bile, and 30 % oxbile (Begley et al., 2002). 
Interestingly many commensial bacteria have much lower bile tolerance. Hyronimus 
et al. (2000) et al. investigated bile tolerance in spore forming lactic acid bacteria, and 
found that only 5 of 13 tested strain tolerated 0.3 % oxbile in the growth media. For 
different Lactobacillus strains tested by Jacobsen et al. (1999) 31 of 47 strains 
completely stopped replication, and 5 strains had delayed growth.  
Although some genera such as Listeria are considered bile tolerant, it seems likely 
that for most bacteria bile tolerance is a strain specific property. For example is 
Enterococcus faecalis ATCC 19433 rapidly killed by 0.3 % bile salts (Flahaut et al., 
1996), while other Enterococcus faecalis strains have been isolated directly from bile 
Introduction 
 11
(Flores et al., 2003). Of the 47 Lactobacillus rhamnosus strains investigated by 
Chateau et al. (1994) 3 strains were classified as resistant, 5 as tolerant, 3 showed low 
tolerance, and 11 were classified as sensitive, when subjected to 0.3 % bile salts. 
Similar results are also seen for other bacteria such as Bifidobacterium, 
Propionibacterium and other Lactobacillus strains. For details see: (Buck & Gilliland, 
1994; Gupta et al., 1996; Ibrahim & Bezkorovainy, 1993; Jacobsen et al., 1999; 
Zarate et al., 2000). To my knowledge only one study is published about bile 
tolerance in B. cereus;  Spinosa et al. (2000), showed that B. cereus AF172711 had a 
minimum inhibitor concentration (MIC) of bile salts below 0.01 %. 
 
It should be noted that the bile tolerance observed for many bacteria in vitro may not 
truly reflect the bile composition and other factors encountered in vivo. In periods of 
starvation the bile concentration in the intestine can be rather low, and exposure to 
such low concentrations (and other type of stresses) may elevate many bacteria’s 
tolerance to bile. Flahaut et al (1996) discovered that when E. faecalis was challenged 
with 0.3 % bile salts only 0.05 % of the bacteria survived. When these bacteria were 
pre-exposed to 0.08 % bile salts for only 15 seconds 85 % of the bacteria survived. 
Experiments done with Bifidobacterium adolescentis  revealed that pre-exposure to 
0.1 % bile resulted in 300-fold protection against 0.3 % bile (Schmidt & Zink, 2000). 
Pre-conditioning to other type of stresses may also elevate bile tolerance. In 
Propionibacterium freudenreichii pre-treatment with SDS, heat (42 ºC) and elevated 
osmolarity induced good protection against otherwise lethal levels of bile salts 
(Leverrier et al., 2003). 
 
Genes involved in bile tolerance 
The genetics of bile tolerance are poorly understood, but this is an area of active 
investigation and some studies have been published. Upon bile challenge bacteria 
initiate stress responses that in many ways are similar to the responses seen when 
challenged with other stresses such as heat, osmolarity, pH etc. Many general stress 
proteins are induced, e. g. GroESL, DnaK, alternative sigma factors, DNA repair 
genes among others (Bernstein et al., 1999; Flahaut et al., 1996; Gahan et al., 2001; 
Leverrier et al., 2003; Leverrier et al., 2004; Rince et al., 2000). Although general 
stress response seem crucial for bile tolerance, more specific responses are also 
essential. The most important factors seem to be active transport of bile acids out of 
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the cell and the action of bile salt hydrolases. In several bacteria a number of 
transporters are up-regulated by bile challenge, and deletion mutants for this type of 
transporter are bile sensitive. Many of these transporters are multidrug transporters 
and also important for resistence other toxic compounds such as antibiotics and heavy 
metals, for details see: (Elkins et al., 2001; Lin et al., 2002; Lin et al., 2005; Thanassi 
et al., 1997; Yokota et al., 2000) Bile salt hydrolases cleave the peptide bond in 
conjugated bile acids, and seem to be an important factor in bile tolerance (Dussurget 
et al., 2002; Elkins et al., 2001; Grill et al., 2000). It has also been proposed that 
bacteria may incorporate unconjugated bile acids and cholesterol in the cell 
membrane, and that this somehow will promote tolerance (Dambekodi & Gilliland, 
1998; Taranto et al., 2003). Not unexpectedly Lactobacillus reuteri (and probably 
many other bacteria) alter the membrane upon bile challenge (Taranto et al., 2003). 
The 7α-dehydroxylation may also be involved in bile-tolerance, but the mechanism 
behind this is not understood. In gram negative bacteria the lipopolysaccaride (LPS) 
has an important role in response to bile challenge (Lacroix et al., 1995; Nesper et al., 
2001; Nesper et al., 2002; Prouty et al., 2002b) Although many of the above 
mentioned genes are involved in protection against bile, we still know very  little 
about the molecular mechanisms behind these protective genes. 
 
Pathogenisis in the Gastroontestinal tract  
Strict regulation of virulence (and other) genes in response to the microenvironment is 
highly important to ensure that cellular energy is not wasted on the expression of un-
necessary genes. Enteric pathogens meet a number of challenges as they enter the GI-
tract. Although these challenges (pH, temperature, iron starvation, bile etc.) are 
potentially harmful to bacteria, many bacteria uses such conditions as environmental 
signals for the induction of a virulent response. (Reviewed by Mekalanos, 1992). It 
seems that many enteric pathogens have co-opted bile as an environmental cue to 
determine the organism's intestinal location so that a temporal pattern of virulence 
factor expression is established (discussed below). 
 
Salmonella typhimurium represses both invasion and flagella genes and thus this 
bacteria represses its invasive capacity in the intestinal lumen where bile 
concentration are high, and invasion then can be initiated where bile concentration are 
lower, e.g. in the mucus layer distal ileum (Prouty & Gunn, 2000; Prouty et al., 2004; 
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Wells et al., 1995). In Vibro cholera bile acids directly induce expression of cholera-
toxin (Hung & Mekalanos, 2005) and motility genes, while other virulence genes are 
down-regulated (Krukonis & DiRita, 2003; Schuhmacher & Klose, 1999), suggesting 
an attempt to move towards lower bile concentration. Both Shigella spp (Pope et al., 
1995) and E. coli (de Jesus et al., 2005) have an elevated ability to adhere to epithelial 
cells which promotes invasion after stimulated with bile. When Enterococcus faecalis 
is incubated with bile it alters the physicochemical properties of its surface, which 
elevates its ability to invade biliary drain materials (Waar et al., 2002). There is not 
much data published on the correlation between bile and pathogenicity and Listeria 
monocytogenes. However, a bile salt hydrolase, under the control of the principal 
regulator of Listeria virulence genes (PrfA), is important for survival in the presence 
of bile and implies a connection between bile and virulence (Dussurget et al., 2002).  
 
When enteropathogenic bacteria have survived the bile challenge, and some of them 
have also initiated the preparation for colonization/invasion by induction of virulence 
genes, they face a new challenge before pathogenicity can be induced; the mucus 
layer. Bacteria have to attach to the mucin layer and to some degree (dependent on 
colonization or invation) also penetrate if they will avoid transportion with the foods. 
The ability to break down mucin is important as bacteria have to penetrate a mucus-
layer that is 25 to 200 times their own length. Little information about bacteria’s 
interaction with the mucus layer is available, but this has been investigated to some 
degree in a few species:  Vibrio cholera induces expression of a protease (Hap) when 
supplemented with mucin in the growth media. This protease hydrolyses mucin and is 
necessary for penetration of a mucin containing gel. In addition it has a role in the 
activation of the cholera toxin (Silva et al., 2003). Alvarez et al. (2003) discovered 
that glyceraldehyde-3-phosphate dehydrogenase is involved in adhesin to the mucus 
layer. In addition the ability to break down carbohydrate monomers may be an 
important factor in degradation and/or adhesion to mucus (Reviewed by Lingwood, 
1998). Some strains of B. cereus do have such an enzyme; 1,2-α-L-fucosidase, which 






1.3 Aims of this study 
 
Problem 
Are pathogenicity and colonization factors induced in Bacillus cereus ATCC 14579 
when factors such as, bile, bile salts or mucin, are encountered in vitro?  
 
The aims of this study are: 
 
(1) Devise a method for the simulation of some of the conditions found in 
the human Gastrointestinal tract, using bile, bile salts and mucin in the 
culture media. 
(2) Determine the physiological response / tolerance of B. cereus ATCC 
14579 to bile, bile salts and mucin. 
(3) Determine the B. cereus ATCC 14579 genetic response to such 
conditions, with focus on surface proteins, using 
i. Real-time-RT PCR 
ii. Microarray (whole genome microarrays) 
iii. 2-D protein gel-electrophoresis 
 
 
Part of the following work was carried out in collaboration with Solveig Sirnes, (real-
time RT-PCR analysis), Ine Robertsen (Bacterial growth and RNA isolation) and Dr. 
Solveig Ravnum (microarray analysis). 
 




2 MATERIALS AND METHODS 
 
2.1 Introduction to the methods section 
2.1.1 Materials, chemicals and buffers 
All materials/kits/solution/buffers, used in this work, and their suppliers, are specified 
in the text where first mentioned. Salts, simple organic compounds and other routinely 
used chemicals were of pro analysis quality and suppliers are not listed.  
 
All buffers were adjusted to the correct pH with 5 M NaOH or 5 M HCl with the 
exception of the phosphate buffer, where 0.2 M Na2HPO2 or 0.2 M NaH2PO2 was used. 
 
2.1.2 Collaboration 
Part of this work was carried out in collaboration with co-students and other 
researchers. Collaboration is specified in the methods section and in the introduction. 
 
2.2 Growth of Bacteria and shift experiments. 
2.2.1 Bacteria strain, culture conditions 
Bacillus cereus ATCC 14579, the type strain of Bacillus cereus, was obtained from 
Professor Anne Britt Kolstø, School of Pharmacy, Oslo University. This strain was 
used in all the experiments. Bacteria were grown in IR-media (Ine Robertsen media, 
table 2.1), which is composed of 50 % LB, 50 % mineral media and glucose. This 
medium gives less variation in the pH  than the more “traditional” media such as LB 
or TSB (Robertsen, 2005). The growth medium was sterilized by filtration through a 
500 ml Stericup® 0.22 µm filter (Millipore, Billerica, Massachusetts, USA). Growth 
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on agar plates was carried out using LB-agar (table 2.1). The LB-agar was sterilized 
by autoclaving and plates were prepared either using a PourMatic® MP-1000 (New 
Brunswick Scientific, N.J. USA) or poured by hand. LB-agar plates with bile salts 
were prepared by autoclaving LB-agar and adding sterile 20 % (w/v) bile salts, Na-
cholate and Na-deoxycholate in 1:1 relation (Fluka, Buchs, Switzerland) to correct 
concentration before pouring the plates. 
 
Table 2.1 Bacteria growth media; IR-media (50 % LB and 50 % glucose mineral media) and LB-plates.     
(1) From Becton, Dickinson and Company, Le Pont de Claix, France.  
IR-medium LB-agar 
K2HPO4 0.8 g Tryptone (1) 10 g 
KH2PO4 0.2 g Yeast extract (1) 5 g 
CaSO4 · 2H2O 0.05 g NaCl 10 g 
MgSO4 · 7H2O 0.25 g Agar (1) 20 g 
Glucose 5 g dH2O to 1 L 
Tryptone (1) 5 g 
Yeast extract (1) 2.5 g  
NaCl 5 g 
dH2O to 1 L 
Dissolve CaSO4 · 2H2O in ~500 ml dH2O, then 
add the remaining ingredients and adjust 
volume to 1 L. 
Sterile filtration. 
Dissolve in dH2O and adjust volume 
to 1 L. Autoclave and cool to  
~50 °C before plating out. 
 
 
The mucin containing medium was very viscous, and impossible to sterilize by 
filtration. Autoclaving could not be used because it would lead to denaturation of the 
mucin proteins, and the sugar molecules would react with peptides or proteins in the 
media. Therefore, the medium containing mucin was prepared by dissolving 5 g 
mucin (from porcine stomach, type III, Sigma, Steinheim, Germany) in 85.6 ml 1 M 
NaOH and incubated over night (ON) at room temperature (RT). This was then 
neutralized by adding 1 M HCl (~85.6 ml). The NaOH and HCl correspond to 5 g 
NaCl, and the IR-medium was prepared without the addition of NaCl. The dissolved 
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mucin was added to sterile IR-medium (without NaCl) prepared in a total of 829 ml 
dH2O to make IR-medium containing 0.5 % (w/v) mucin. The mucin media were 
streaked out on LB-plates to check if previously detected bacteria were present. 
 
Unless otherwise noted, bacteria were grown at 37 °C with shaking at 175 rpm in 1 L 
Erlenmeyer flasks containing 100 ml IR-medium. The growth medium was preheated 
to 37 °C ON and checked for contamination prior to use. One vial of ON culture (10 
µl suspension with 3 µl 87 % glycerol), section 2.2.2, was used as the inoculum per 
100 ml growth medium. Standard sterile technique was employed in all experiments 
and the bacterial suspensions were checked for contamination by microscopic 
examination in a Biomed phase contrast microscope (Leitz, Portugal). 
 
2.2.2 Generation of over night cultures 
To eliminate possible changes in the bacterial strain during the period of this work a 
large stock of ON cultures was prepared. Approximately 10 µl of a Bacillus cereus 
ATCC 14579 suspension was plated out on LB plates and grown ON at 30 °C. 
Twenty ml IR-media in a 100 ml Erlenmeyer flask was inoculated with one well 
isolated colony and grown ON (~16 h.) at 37 °C with shaking at 175 rpm. The cell 
density of the suspension was determined by flow cytometry. Approximately 50 x 10 
µl suspensions were mixed with 50 X 3 µl 87 % glycerol and stored at -70 °C until 
use.  
 
2.2.3 Growth curves and measurement of pH, glucose and the cell density 
To establish the growth curve one batch of ON cultures was inoculated into 100 ml 
IR-media and grown until the culture was well into the stationary phase. Samples for 
the measurement of pH, glucose and the cell density were taken every hour.  
 
pH was measured by applying 20 µl suspension to Neutralit® or Acilit® pH strips 
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The concentration of glucose in the media was measured using Glucose (GO) assay 
from Sigma. One ml of bacteria solution was removed every hour for a total of 10 
hours after inoculation. The bacteria solution was filtrated through a 0.22 µm pore 
filter and stored at 4 ºC over night. One glucose-oxidase/peroxidase-reagent capsule 
was dissolved in 39.2 ml dH2O, before 0.8 ml o-Dianisidine Reagent was added. All 
the samples were diluted in dH2O to give a glucose concentration below 50 µg/ml. IR-
medium was used to make a standard with concentrations between 0 and 60 µg/ml 
glucose. Two ml assay reagent was added to each sample in a 5 ml polystyrene tube. 
The tubes were incubated in the dark for 30 min at 37 ºC. The reaction was terminated 
by adding 2 ml 6 M H2SO4. Absorbance was measured at 540 nm on a PU 8750 
UV/VIS Scanning spectrophotometer from Philips (UK).  
 
The bacteria cell density was measured using the Bacteria Counting Kit from 
Molecular Probes (Eugene, Orgeon, USA) and counted on a Becton Dickinson 
FACSCalibur Flow Cytometer, with the software: BD CellQuest Pro (both: Becton 
and Dickinson, San Jose, California, USA). The bacteria suspension, 500 µl, was 
diluted 5X, 10X, 100X or 1000X to give a measurement between 200 and 2000 
fluorescent units, and a number of reference sphere fluorescent units between 100 and 
1500. One µl of florescent dye and 10 µl microspheres were added to 1 ml of the 
diluted bacterial suspension. The forward scatter emission was measured at 500 nm 
for both the bacteria and the spheres and the bacterial density was calculated using 
formula (1) shown below. Three measurements were made for each time point sample 
and the average cell number was used. The standard deviation between each 
measurement was below 10 %. 
 
 Cell density (cell#/ml) = fs(bacteria)/fs(spheres) x 106 x dilution factor,  (1) 
 
where fs is the number of florescent units from either the bacteria or the spheres.  
2.2.4 Calculations  
Generation time 
The generation time in exponential phase was estimated using the following formula 
(2) 
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 n = 3,3 x (log N – log N0) 
 g = t/n,      (2)  
 
where n is the number of generations, N is the final cell number and N0 is the start cell 
number. g is the generation time and t is the time in minutes. 
 
Standard deviation 
The standard deviation between parallel measurements (cell density, log2 ratios, etc) 
in this work was calculated with the non-biased method, formula (3).  
   
      ∑(xi – x) 2 
 Standard deviation  =     √                             (3), 
                      n 
 
where n is the number of observations, xi is the value of each observation and x is the 
average of all observations 
 
2.2.5 Growth of Bacillus cereus in the presence of bile and bile salts. 
A concentration screening was performed to investigate Bacillus cereus ATCC 14579 
tolerance towards bile and bile salts. Two vials with frozen ON-cultures were cultured 
in 205 ml IR-medium in a 1 L Erlenmeyer flask at 37 °C and 175 rpm. After 2.5 hours 
(for the bile culture) and 3 hours (bile salts culture) the culture was portioned into 
(volume?) four 1 L flasks and bile (Ox-bile, partially purified, Fluka) or bile salts 
were added. The final concentrations were, bile; 0 %, 0.0125 %, 0.0375 % and 0.375 
% (all w/v) and bile salts; 0 %, 0.001 %, 0.005 % and 0.01% (all w/v) respectively.  
 
2.2.6 Bile salts adaptation 
The following experiment was performed to test if B. cereus ATCC 14579 would 
tolerate higher concentration of bile salts after a prior exposure to a low 
concentration..  
 
B. cereus ATCC 14579 was grown for 3 hours in 205 ml IR-media. The culture was 
divided in two and shifted to new media; 100 ml was shifted to 100 ml IR-medium 
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with no additives. 100 ml was shifted to 100 ml IR media containing 0.01 % (w/v) 
bile salts, to give a final concentration of 0.005 %. Samples were removed after 5 
(bile salt culture) and 30 minutes (bile salt and control). The suspensions were diluted 
2000X (bile salts, 5 min), 3333X (bile salts, 30 min), and 3846X (control, 30 min) and 
100 µl were plated out on LB-agar plates with concentrations of bile salts ranging 
from (all w/v): 0.001 %, 0.005 %, 0.01 %, 0.02 %, 0.05 %, 0.10 %, 0.20 %, 0.50 %, 
and 1 %. The diluted suspensions were plated out in triplicate for each concentration 
of bile salts. To determine the number of bacteria plated out from each dilution, each 
dilution was diluted further; 10X and 100X and plated on LB-agar plates. Plates were 
incubated ON at 37 °C. The experiment was repeated once. 
 
2.2.7 Shift experiments 
A culture of B. cereus ATCC 14579 in exponential growth was shifted to new media 
containing different additives (bile, bile salts and mucin). A start culture with 410 ml 
IR media in a 3 L Erlenmeyer flasks was inoculated with 4 vials of ON culture. The 
start-culture was grown for 3 hours and  4 x 100 ml aliquotes were removed and 
added to 4 new flasks containing: 1) 100 ml IR medium (control);  2) 100 ml IR-
media containing 0.06 % (w/v) bile which gives a final concentration of 0.03 % (w/v) 
bile; 3)  100 ml IR-media containing 0.01 % (w/v) bile salts which gives a final 
concentration of 0.005 % (w/v) bile salts; 4) 100 ml IR-media containing 0.5 % (w/v) 
mucin which gives a final concentration of 0.25 % (w/v) mucin. All pre-equilibrated 
to 37 °C. A schematic presentation is shown in figure 2.1. 
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Figure 2.1 Shift experiment. After three hours of growth the start culture was shifted to four new flasks 
containing 100 ml IR to give four new 200 ml cultures containing: A – no additives, B 0.03 % (w/v) 
bile, C 0.005 % (w/v) bile salts and 0.25 % (w/v) mucin. 
 
 
Samples for RNA isolation and cell counting for RealTime RT PCR were removed 
after 0, 5, 10, 20, and 30 minutes (in collaboration with Solveig Sirnes). 
 
Samples for RNA isolation and cell counting for microarray analysis were removed 
after 0, 15, 30, and 60 minutes. The mucin shift culture was not used. (In 
collaboration with Ine Robertson.) 
 
Samples for protein isolation and cell counting were removed at 0 and 30 minutes 
from the control (A) and after 30 minutes for bile (B) and bile salts (C) cultures. The 
mucin shift culture was not used in the 2D-protein electrophoresis experiment.  
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2.3 In silico investigation of potential virulence genes and PCR-
primer selection 
2.3.1 Criteria for the selection of potentially interesting genes.  
Potentially interesting genes for use in real-time RT-PCR were selected using the 
following criteria; they should in some way be involved in virulence, they should be 
associated with the cell wall or membrane and finally, they should possibly be up-
regulated when the bacteria encounter the types of conditions which are found in the 
human intestine. Few cell wall/membrane virulence factors are documented in 
Bacillus cereus therefore the presence, in Bacillus cereus, of homologues of known 
virulence factors in other gram positive bacteria was investigated. In addition, the 
presence of a plcR–box in the promoter region of the said genes was also investigated. 
On the basis of these criteria several genes were identified (see section 3.2.1) and 
three of them were selected for further analysis using Real-time RT PCR. The 
selected genes were two internalin A genes and a fibronectin binding protein gene 
(primers named; intA, intB, and fbp, respectively) The gene for glyceraldehyde-3-
phospate dehydrogenase (primer named gap) was chosen as a reference. 
 
2.3.2 Analysis of genes coding for potential virulence factors using bioinformatics 
The amino acid sequence similarity between Bacillus cereus ATCC 14579 genes and  
known virulence factors from Listeria monocytogenes and Streptococcus spp. 
(sequences obtained form NCBI, www.ncbi.nlm.nih.gov/) was detected using the 
basic local alignment program, “blastp” or “tblastn” provided in the EMBOSS 
package (http://emboss.sourceforge.net/). The similarity between potentially 
homologous genes was further investigated by generating a Needleman-Wunch global 
alignment, with the BLOSUM62 matrix (or the BLOSUM20 matrix for distantly 
related sequences), between the sequences of interest, using the “needle” algorithm in 
the EMBOSS package. Multiple alignments were generated with the clustalW 
program (ver. 1.83), with the BLOSUM62 matrix in the EMBOSS package. The 
genes were investigated for known domains or motifs by using the integrated 
motif/domain database; Interpro (www.ebi.ac.uk/InterProScan). Interpro scans several 
domain/motif databases: BlastProDom, HMMTigr, TMHMM, FPrintScan, 
ProfileScan, HMMPanther, HMMPIR, ScanRegExp, HMMPfam, SuperFamily, 
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HMMSmart and SignalPHMM. In the results section reference is made to the actual 
database in which the domain/motif was found, even though the search was 
performed at Interpro. To scan for plcR consensus binding sequences an embl 
formatted sequence of the Bacillus cereus ATCC 14579 genome (downloaded from 
http://www.ebi.ac.uk/cgi-bin/sva/sva.pl?) was uploaded to Artemis, and the sequence 
was queried with the consensus sequence (plcR: tatgnannnntncata) with variables. 
The gene was interpreted as a putative plcR regulated gene if the consensus sequence 
was found 20 to 200 nt upstream of the translation start of the gene in question 
(Slamti & Lereclus, 2002). 
 
2.3.3 Oligonucleotide primer selection 
The DNA sequences for BC0552 (IntA), BC1331 (IntB), BC3873 (fbp) and BC5141 
(gap) were obtained from the KEGG (Kyoto Encyclopaedia of Genes and Genomes, 
www.kegg.com) database. Primers were selected using eprimer3 in the EMBOSS 
package. The optimum melting temperature was set to 60 °C, the primer size to ~20 nt 
and the product size to ~200 nt. Primers containing 4 or more repeats of the same base 
were excluded. The primers were then checked for similarities in the Bacillus cereus 
genome using “blastn” in the EMBOSS package. The primers were synthesized by 
MWG-BIOTECH AG (Ebersbergand, Germany) and are listed in table 2.2.  
 
Table 2.2 Oligonucleotide primers: F – forward primer, R – reverse primer. The full gene names are 




Oligonucleotid sequence Tm  Product size 
fbpF TGGCTCTCACGTTGTCATTC 57.3 °C 
fbpR TACGGTTTGCTGATTGTCGT 55.3 °C 
193 
intAF ACGAGCCAACAACAGGAGTT 57.3 °C 
intAR TTGTCCACCTGTTGCTCCTA 57.3 °C 
200 
intBF TGAAACGGCTATTGATGCAG 55.3 °C 
intBR CACATATCCTTTCGCCCAAT 55.3 °C 
196 
gapF  ACGCGGAATGATGACAACAA 55.3 °C 
gapR  ACAGCGCCACCGTTTAATTT 55.3 °C 
183 
Materials and methods 
 24
2.4 Real-time RT-PCR (in collaboration with Solveig Sirnes) 
Expression pattern of internalin and fibronectin binding protein genes under bile, bile 
salts and mucin stimuli was investigated by Real-time RT-PCR. RNA was isolated 
from all cultures (A, B, C, and D, see section 2.2.7) at different time intervals (0-5-10-
20-30 min.) after the shift. 
 
2.4.1 RNA isolation  
RNase free filter tips and DEPC (DiEthylPyroCarbonate)-treated water (0.1 % (v/v) 
DEPC in dH2O, stirred for 24 h and autoclaved) was used in all the experiments in 
this section.  
 
Samples (10 to 20 ml bacteria suspension corresponding to ~1x109 cells) were 
removed from the shifted cultures and added to an equal volume of ice-cold methanol 
and incubated for 5 minutes at RT to kill the bacteria. The suspensions were then 
stored on ice until they were pelleted by centrifugation at 4 °C and 4000 x g (rcf) in an 
IEC centra cl3 centrifuge (Thermo Electron Corporation). The supernatant was 
removed and the bacteria pellets were stored at – 70 °C until the day of usage 
(maximum 2 days). 
 
Total RNA was isolated using the FastRNA® Pro Blue Kit and the FastPrep® FP 120 
Instrument from Qbiogene (Illkirch Cedex, France) according to the manufactures 
protocol (appendix I). The pellet from the shift experiments was used. The samples 
from the medium containing mucin were re-extracted using chloroform:isoamyl 
alcohol (24:1 v/v) (point 12 in the protocol, see appendix I). The isolated RNA was 
dissolved in 100 µl DEPC-treated H2O and stored at -70 °C. 
 
RNA concentrations were determined by diluting RNA in DEPC-treated water and 
measuring the absorbance 260 nm on a PU 8750 UV/VIS Scanning 
spectrophotometer. The RNA purity was estimated by measuring the ratio of the 
absorbance at 260 nm and 280 nm. The RNA was diluted to give absorption (A260nm) 
between 0.1 and 0.9 before measuring, and the concentrations were calculated using 
following formula (4). 
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 μl RNA/ml = Dilution factor x 40 x A260nm      (4) 
 
RNA purity was estimated by dividing the A260nm on A280nm. 
 
Denaturing formaldehyde gel electrophoresis was used to estimate the RNA integrity 
and possible DNA contamination. To prepare the gels, 1.2 % (w/v, final 
concentration) agarose was melted in DEPC-treated water by heating in microwave 
oven. After cooling 10X MOPS-buffer and formaldehyde (12.3 M) was added to final 
concentrations of 1X and 2.2 M, respectively. MOPS-buffer (10X) contains: 2 M 3-N-
morpoline propane sulfonic acid (MOPS), 800 mM Sodium acetate and 100 mM 
EDTA (pH 8).  
 
The following: 5.0 μl RNA or RNA ladder; 2.0 μl 10xMOPS buffer; 1.0 μl DEPC-
water; 2.0 μl formaldehyde and 10.0 μl formamide were mixed in a PCR tube and 
samples were denatured by heating at 70 °C for 15 minutes. Eight µl of the samples 
were then mixed with 2 µl GEL loading buffer (New England Biolabs, Ipswich, MA, 
USA) and loaded on the gel. RNA ladder (10 µl) was also loaded (New England 
Biolabs). The gel was run in 1X MOPS buffer for ~70 minutes at 3.5 V/cm (70 V for 
20 cm gels) in a fume hood. The gel was stained using 0.5 µg/ml ethidium bromide in 
0.1 M ammonium-acetate (in DEPC-treated H2O) for 45 minutes then destained in 
DEPC-treated H2O ON. 
 
 
2.4.2 Testing of the PCR-Primers  
The specificity of the primers were tested by with the amplification of genomic DNA 
extracted from Bacillus cereus ATCC 14579 followed by agarose gel electrophoresis 
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The following was mixed in a PCR tube (A master-mix was used for buffer, dNTPs, 
water, and DNA template):  
 2.5 μl    10x PCR reaction buffer (Finnzymes, Espoo, Finland) 
 1.25 μl   dNTP (200 μM) 
 16.25 μl dH2O 
 2.0 μl    DNA template 
 2.5 μl    Forward and reverse primers (0.2 μM of each)   
 0.5 μl   DyNAzymeTM II DNA polymerase (Finnzymes) 
 
PCR was performed with following protocol: 
 Initial denaturation 2 min 94 ˚C 
 Denaturation   30 sec  94 ˚C─┐ 
 Annealing   30 sec  58 ˚C 30x 
 Elongation  30 sec  72 ˚C─┘ 
 Final elongation 5 min 72 ˚C 
 
A 1.5 % (w/v) agarose gel was prepared by mixing 0.75 g agarose (Sigma) in 50 ml 
1X TAE and heating in microwave oven until all the agarose was dissolved. Five µl 
PCR product or 5 µl 100 bp ladder (New England Biolabs) were mixed with 5 µl 1 X 
Gel loading buffer (New England Biolabs) and loaded on the gel. Electrophoresis was 
preformed at 80 V for ~50 min. The primers tested are listed in table 2.2 
 
TAE (1X) contains 4.84 g Tris (2-Amino-2-(hydroxymethyl)-1,3-propanediol), 1.14 
ml glacial acetic acid, 2.00 ml 0.5 M EDTA (ethylenediaminetetraacetic acid) (pH 8.0), 
to 1 L with dH2O. 
 
2.4.3 Real-time PCR 
The mRNA levels of fbp, intA and intB in the shift experiments were determined by 
real-time RT-PCR.  
 
DNase treatment 
Samples were treated with DNase to remove any traces of genomic DNA prior to 
reverse transcription. The Deoxyribonuclease I, Amplification Kit from Invitrogen 
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Ltd. (Paisley, UK) was used. For each target sequence (to be amplified by reverse 
transcriptase) one µg RNA was used. The following was mixed in a tube: 
 1 µg RNA 
 1 µl 10 X buffer  
 1 µ1 DNase was added. The reaction volume was adjusted to  
 to 10 µl with DEPC-treated H2O. 
The reaction was incubated at RT for 15 minutes, stopped by adding 1µl 25 mM 
EDTA for each 10 µl reaction volume and incubated at 65 °C for 10 minutes. 
 
Reverse transcriptase 
Synthesis of cDNA was performed by reverse transcription of mRNA using the Super 
Script™ II Reverse Transcriptase Kit (Invitrogen). The following was mixed in a        
tube: 
 11 µl DNase treated RNA (1 µg) 
 1 µl gene specific reverse primer (2 pmol/µl) 
 1 µl dNTP mix (10 mM each) 
The mix was incubated at 65 °C for 5 minutes, chilled on ice and 4 µl 5 X First strand 
buffer and 2 µl 0.1 M DTT was added. The mix was pre-heated for 2 minutes at 42 °C 
before 1µl Superscript™ II reverse transcriptase (200 U/µl) was added. The reaction 
was incubated at 42 °C for 50 min and terminated by heating at 70 °C for 15 minutes. 
 
Real-time PCR, principle 
Real-time PCR can be used in the relative quantification of cDNA (mRNA). A 
fluorescent dye (SYBR® Green), which binds to dsDNA, can be used to estimate the 
amount of PCR product formed after each PCR cycle. This data can in turn be used to 
determine the relative abundance of one population of starting molecules with 
another. The point where each reaction reaches the logarithmic growth, called the Ct-
value, is proportional to the amount of starting material. A reference gene comparison 
is necessary in order to eliminate differences between samples caused by differences 
in RNA (cDNA/DNA) concentration in the starting population. The expression of 
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Procedure 
Real-Time PCR was performed on a LightCycler® instrument provided by Roche (F. 
Hoffmann-La Roche Ltd, Diagnostics Division, Basel, Switzerland). The reaction was 
carried out using the DyNAmo™ Capillary SYBR® Green qPCR kit from Finnzymes 
in LightCycler® Capillaries (Roche). The cDNA samples were diluted in series to 10-
1,     10-1.5, 10-2, 10-2.5 and 10-3 dilution (see figure 2.2).  
 
Figure 2.2 Dilution series describing how to prepare 10-1, 10-1.5, 10-2, 10-2.5, 10-3 dilutions of reverse 
transcription products prior Real-time PCR.  
 
Diluted cDNA (5 µl), primer (5 µl, forward and reverse, 2 µM each), and 2X Master 
mix (10 µl, containing SYBR® Green, enzyme and reaction buffer) were gently mixed 
and loaded in the capillaries, spun down and placed in the LightCycler® rotor. DNase 
treated RNA was used as a negative control. This was diluted 10-1.26 to obtain the 
same dilution as the 10-1 diluted cDNA (The DNase treated RNA is further diluted 
through the reverse transcription, hence the extra dilution.) The PCR was run using 
the program listed in table 2.3. The results were analyzed using Roche Molecular 
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Table 2.3 Cycle program for Real-time PCR for analysis of expression and melting curves. 
  
Melting curve analysis was performed on the PCR products in order to check for 
product contamination from primer dimers, chimer formation and mispriming. 
SYBR® Green binds to dsDNA and the fluorescent signal will be reduced as the 
dsDNA melts. By plotting the time-derivate of the relative fluorescent units (RFU) on 
the Y-axis (-d(RFU)/dT) and degrees on the X-axis a peak for each dsDNA product 
will be generated. More than one peak indicates more than one PCR product. 
 
The following genes were investigated; intA, intB and fbp at  time 0 and 30 minutes 
after the shifts in all cultures (A – D). 
 
The real-time PCR products were subjected to 1.5 % agarose gel electrophoresis in 
order to verify that the correct product was amplified. Five µl real-time PCR product 
were mixed with gel loading buffer and run for ~50 minutes at 80 V. (For details 
about agarose gels; see section 2.4.2) Each sequence was loaded (intA, intB, fbp and 
gap) and in addition two products that showed a large difference in expression; intB 
and gap with Ct values of 34.33 and 12.33, respectively.  
 
2.4.4 Mathematical and statistical Analysis of Real-time RT-PCR results 
2.4.4.1 Amplification efficiencies 
The amplification efficiency is a measurement of the efficiency of the PCR-
amplification. Generally, each primer pair and its target sequence has its own 
amplification efficiency that is unique for this sequence. It describes how efficient the 
PCR reaction is under the specified conditions. To determine the amplification 
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efficiency for a sequence, a dilution series for the sequence is generated, a regression 
curve is plotted, and a regression curve analysis is preformed. (Lunde et al., 2003) 
The following formula (5) describes a PCR reaction in the exponential phase: 
 
 Xn = X0 * (1 + EX)n       (5) 
 
Where Xn is the number of target molecules in cycle n, X0 is the number of target 
molecules before amplification, Ex is the amplification efficiency of the target 
sequence and n is the number of cycles. The formula can be reorganized to give 
amplification efficiency (6): 
 
 Ex = (Xn / X0) 1/n – 1      (6) 
 
A regression line was generated for each different sequence by plotting the Ct-value 
(Y-axis) against the log10 of dilution factors (X-axis). The regression line is found by 
the least square method. A minimum of 4 points was used to generate the regression 
line and 0,990 was the cut-off for the correlation efficient (R2) (The correlation 
efficient shows how well each point is fitted to the straight line), hence all lines 
generated with less then 4 points or a correlation efficient < 0,990 were discarded. An 
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Figure 2.3 Example of a regression curve for the calculation of amplification efficiencies. Log10 of the 
dilution factors were plotted against the respective Ct-values. The absolute value of the slope (here: 
3.43) is the number of cycles needed to get a ten-fold doubling of the initial cDNA. This example is 
from one of the regression curves for fbp. 
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Each unit at the X-axis corresponds to the ten-fold increase in the amount of product, 
and thus Xn/X0 can be set to 10. The absolute value to the slope of the regression line 
then describes how many cycles are necessary to ten-double the amount of the 
product sequence. The amplification efficiency of a sequence can thus be given by the 
formula (7):  
 
 Ex = 101/n – 1,       (7) 
where n is the absolute value to the slope  
 
2.4.4.2 Reference gene 
The reference gene is used to normalize the PCR for the amount of RNA added to the 
reverse transcription reactions. Usually, housekeeping genes are selected, since they 
are thought to be equally expressed throughout the cell cycle. The expression of 
glyceraldehyde-3-phosphate dehydrogenase (gap, BC5141) was measured throughout 
the 30 minutes time-window after the shift in which the samples were taken. The 
expression of a reference gene is presented as 2-ΔCT, where ΔCT (CTtime x – CTtime 0), 
and time 0 represents the 1-fold expression of each gene (Schmittgen & Zakrajsek, 
2000). 
 
2.4.4.3 The Pfaffl method, relative quantification 
Pfaffl presented in 2001 a new method to quantify gene expression using RealTime 
RT-PCR (Pfaffl, 2001). This method will normalize the expression of a target gene to 
the expression of the reference gene, thus removing sources of error such as unequal 
RNA concentrations in different samples and pipetting inaccuracies and is given by 
the following formula (8). In addition, this method will account for different 
amplification efficiencies between different sequences. 
 
    (Etarget) ΔCTtarget (CTcontrol – CTsample) 
 Ratio =  _________________________                 (8)                                       
   (Eref) ΔCTref (CTcontrol – CTsample) 
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Where “target” is the sequence under investigation and “ref” is the reference gene; 
Etarget and Eref describe the amplification efficiency + 1 of the target sequence and the 
reference sequence, respectively. ΔCT is the deviation in CT value between the 
control (in this work A0) and the sample we are investigating the expression of, for 
both the target gene and the reference gene. The ratio thus describes the fold increase 
of expression in the sample compared to the control (relative to the expression of the 
reference.) By using this method, both the difference in amplification efficiencies for 
different sequences and sample to sample differences, will be accounted for.  
 
2.5 Microarray (in collaboration with Ine Robertson and Solveig Ravnum) 
2.5.1 Shift experiments and RNA isolation for microarray 
Shift experiments were performed as described in 2.2.7, but without the mucin 
culture. Samples for RNA isolation was removed at 0, 15, 30, and 60 minutes after the 
shift.  
 
The RNA isolation was performed by Ine Robertsen as described in 2.4.1. 
Concentrations and A-260nm/A-280nm-ratios were measured and RNA integrity was 
examined on denaturing agarose formaldehyde gels as described (2.4.1). 
2.5.2 cDNA labeling and microarray hybridization  
The microarray hybridization was performed by Solveig Ravnum. cDNA synthesis 
and labeling was done with the FairPlay™ microarray labeling kit (Stratagene, CA, 
USA). Except for the use of random hexamers (500 ng, Applied biosystems (CA, 
USA)) as primers, the protocol (appendix II) was followed in all steps. In brief; RNA 
(10 µg) and spike mixture (Stratagene) were reverse transcribed, purified and labeled 
with amino-allyl coupling of Cy3 and Cy5 dyes (Amersham, Uppsala, Sweden). The 
labeled cDNA was denatured (95 °C, 2 min.) and left at 42 °C for 20 minutes before 
hybridization.  
 
Hybridization was done according to Cornings (MA, USA) manual (UltraGAPS™ 
Coated Slides instruction manual (appendix II). The slides was pre-hybridized, 
hybridized over night at 42 °C and washed, see appendix II for details. 
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The cDNA was hybridized on arrays of 70-mer oligos of the whole genomic B. cereus 
ATCC 14579 ORFs. The 70-mers were designed and synthesized by Qiagen-Operon 
(CA, USA) and printed on UltraGAPS™ gamma amino silane coated slides from 
Corning, with the Midigrid Biorobotics arrayer at the Norwegian Radiumhopspital 
(Oslo, Norway). In addition the array has both positive/negative controls and 70-mer 
oligos corresponding to Arabidopsis thaliana RNA spikes. Each 70-mere is replicated 
in pairs, and each array is replicated once on the slide, thus each 70-mere is in 4 
replica on each slide. 
 
Since the two dyes Cy3 and Cy5 have somewhat different affinity towards the same 
sequence a dye-swap was performed: Two replicates were performed per 
hybridization where the hybridization-pair was labeled opposite in the replicate. 
 
RNA from cultures A30, B30, and C30 was hybridized against A0. This was done in 
two biological replicates, where each of these was replicated by dye-swap. Ten µg 
RNA from each sample was used. 
 
2.5.3 Microarray analysis 
The slides were scanned with an Axon 4000B (Molecular Devices Corporation, CA, 
USA) Gridding and spot annotation were done using the GenePix Pro 6.0 software 
(Molecular Devices Corporation), and results for each spot were calculated with the 
same software. 
 
The microarray data was analyzed with an R-script developed by Karoline Fægri, 
Institute of pharmacy, Oslo University, in R 2.0.1 (R-Development-Core-Team, 2004)  
with the package Limma (Smyth, 2005). The gene-pix files were imported to R and 
the package Limma was used for filtering, normalization and further analysis. The 
dye-swap was inverted. The mean red and green foreground values and median red 
and green background values were used. The data were first filtered so that all control 
spots were weighted to zero, while spots that were flagged bad in GenePix, saturated 
in both channels or weak in both channels were weighted to no answer. The saturation 
limit was set to 60 000. Lower threshold value was set to intensity lower than 2 x 
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background. Spots that were weak in one channel and saturated in the other were not 
removed, because the effect is significant even if the ratio is not absolutely correct. 
 
Background correction was done using the Edwards method (Edwards, 2003). 
Normalization within each slide was done with the loess method (Cleveland et al., 
1993). Spots that were not present in at least two replicas per slide were filtered out. 
The average of each spot in each slide was fitted to the corresponding spot in the 
biological replicate. The model was evaluated using Bayesian statistics and moderated 
t-statistics were computed. On basis of this, P-values were computed. 
 
The average log2 ratio (A30, B30 or C30 divided on A0) for each spot is given along 
with the P-value. All spots with P-value equal to or above 5 % were filtered out. For 
B30/A0 and C30/A0 only spots with absolute log2 ratio above 0.59 were selected and 
listed. All spots in A30/A0 with P-value under 5 % were included in this list. Lists of 
filtered spots were generated.  
 
The lists of significant spots were further analyzed in excel, and grouped according to 
function by using information about each gene available from KEGG 
(www.kegg.com). 
 
2.6 Protein extraction and 2-D electrophoresis  
2.6.1.1 Determination of protein concentration 
The concentration of protein was determined using the Bio-Rad Protein Assay (Bio-
Rad Laboratories, CA, USA). Protein extract (0.5 µl to 5 µl) was diluted in 20 mM 
Tris (pH 7.5) to a total volume of 160 µl and dispensed into a microtitrer plate. Forty 
µl undiluted dye reagent was added, mixed thoroughly and incubated at RT for 8 
minutes. The absorbance was measured at 595nm. The A595nm was the compared to a 
standard curve (see below), and the protein concentration was determined. 
 
Two standard curves were prepared using BSA (Bovine Serum Albumin): 1) from 1 
µg to 5 µg (A595nm between 0.420 and 0.600) and 2) from 5 µg to 20 µg (A595nm over 
0.600). Samples with A595nm under 0.420 or over 0.900 were concentrated or diluted 
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to give an A595nm in the correct range. The same standard curves were used for all 
experiments.  
 
2.6.1.2 Extraction of total cell proteins 
Principle 
Two procedures were used in the extraction of total cell proteins; one in which the 
cell pellet was suspended in 20 mM tris (pH 7.5) containing protease inhibitor for use 
in the aminopeptidase C assay (section 2.6.2.2) and one in which the cell pellet was 
suspended in lysis buffer containing strong denaturants. The lysis buffer is more 
hydrophobic and better recovery of hydrophobic proteins (such as membrane 
proteins) is expected. The FastPrep® method was used to disrupt the cells. The angular 
motion of the FastPrep® instrument causes the lysing matrix particles to impact the 
cells from all directions simultaneously, and thus disrupting them. Both buffer 
extracts were analyzed by 2-D protein gel electrophoresis. 
 
Procedure 
The protease inhibitor used in the following experiments was Complete Protease 
Inhibitor Cocktail Tablets (Mini, EDTA-free) from Roche. One tablet was dissolved 
in 500 µl dH2O to make 21X concentration. This was added to the buffers to a final 
concentration of 1X.  
 
 
IR-media (200 ml) was inoculated with 2 vials of ON-culture and grown for 3 h. at 37 
°C, at 175 rpm. in a 1 L Erlenmeyer flask. The culture was shifted to 2 x 100 ml fresh 
IR-media (with no additives) and harvested immediately by centrifugation, 4000 x g 
(rcf), 4 °C for 15 minutes Sorvall® RC-5B Refrigerated Superspeed Centrifuge 
(DuPont instruments, France). The cell pellets were washed for 1 minute with shaking 
(175 rpm, 4 °C) in 20 mM Tris (pH 7.5) containing protease inhibitor and centrifuged 
at 4000 x g at    4 °C for 10 minutes. One cell pellet was suspended in 1 ml 20 mM 
Tris (pH 7.5) containing protease inhibitor and the other cell pellet was suspended in 
1 ml lysis buffer ((7 M Urea, 2M Thiourea and 4% (w/v) CHAPS (3-[(3-
Cholamidopropyl)-dimethylammonio]-propanesulfonic acid)). This is the same as the 
rehydration buffer described in 2.6.3.2, but without bromophenol blue. Both samples 
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were transferred to lysing matrix A tubes and homogenized in the FastPrep® 
instrument at setting 6 for 40 seconds. The samples were centrifuged at 13 000 rpm 
for 2 minutes in a microsentrifuge, transferred to new tubes and centrifuged again for 
5 min (13 000 rpm) in order to remove any protein aggregates or cell debris. The 
supernatants were transferred to new tubes. Protein concentrations were measured, 
and samples for the determination of aminopeptidase C activity were collected.  
 
The samples were concentrated as described below in section 2.6.2.1 prior to 2D 
protein electrophoresis. There were some exceptions for the proteins extracted with 
the lysis buffer; lysis buffer was used as the dialysis buffer and because of the high 
viscosity of the lysis buffer the centrifugation time was increased to 3 hours and 
performed only twice. 
 
2.6.2.1 Testing of different extraction buffers  
A number of different buffers were tested in the isolation of proteins “loosely” 
associated with the bacterial cell. The principle of this method is that relatively mild 
buffers will dissociate loosely attached surface proteins without disrupting the 
integrity of the cells. Covalently, or strongly attached surface proteins, however, will 
not be dissociated.  
 
IR-media (400 ml) was inoculated with 40 µl ON-culture and grown for 3 h. at 37 °C, 
175 rpm. The culture was shifted to 4 x 100 ml fresh IR-media (with no additives) and 
harvested immediately by centrifugation, 4000 x g (rcf), 4 °C, for 15 minutes. The cell 
pellets were washed in 1 ml 20 mM Tris (pH 7.5) containing protease inhibitor. The 
supernatant from the washing step was collected. The cell pellets were extracted with 
different buffers (see table 2.4 below) for 10 minutes with gentle shaking (175 rpm) at 
4 °C and pelleted by centrifugation. The supernatants were collected and designated 
“buffer extracts”. For comparison the remaining cell pellets were supended in 20 mM 
Tris (pH 7.5) and lysed using FastPrep® method (as described in 2.6.1.2). Both the 
washing extraction and the buffer extractions were additionally centrifuged for 10 min 
at 4000 x g (rcf), 4 °C and transferred to new tubes. All extractions and the washes 
were analyzed for aminopeptidase C activity.  
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Table 2.4 Extraction buffers for protein isolation.  
Buffer# 
20 mM Tris (pH 7.4) (1) 
1X PBS(2) (pH 7.0)  
1 M Tris (pH 7.4) 
1 M KSCN(3) in 20 mM Tris (pH 7.5) 
0.01 % NP-40(4) in 20 mM Tris (pH 7.5) 
0.1 % (w/v) CTAB(5) in 20 mM Tris (pH 7.5) 
0.01 % (v/v) Triton X-100 in 20 mM Tris (pH 7.5) 
1.5 M LiCl in 20 mM Tris (pH 7.5) 
#All buffers contain 1X protease inhibitor. 
(1)Wash step – 1 min only 
(2)Phosphate buffer saline (0.26 g NaH2PO4 x H2O, 1.49 g Na2HPO4 x 2H2O, 8.77 g NaCl  to 1 L with 
dH2O) 
(3)Potassium thiocyanate 
(4)Nonidet® P 40 (Shell chemicals) 
(5)Hexadecyltrimethylammonium bromide 
 
Concentration of protein samples prior to SDS-PAGE 
Samples were concentrated by ultrafiltration; the samples were transferred centricon 3 
ultrafiltration devices (3 kDa cut-off, from Millipore) and centrifuged at 6500 x g (rcf) 
at 4 °C for 2 hours. To collect the concentrated samples the tubes were inverted and 
centrifuged (600 x g (rcf), 4 °C, 1 min.). To remove traces of proteins retained in the 
filter 5 µl 5 mM Tris (pH 7.5) containing protease inhibitor was added and the 
centrifugation was repeated (600 x g (rcf), 4 °C, 2 min.). 
 
Concentration and dialysis of protein samples prior to 2-D electrophoresis 
In 2-D electrophoresis the salt concentration is crucial, and should not exceed 20 mM. 
In order to achieve this 1 ml 5 mM Tris (pH 7.5) containing protease inhibitor was 
added to the samples and transferred to the ultrafiltration tubes. The samples were 
centrifuged for 2 hours (6500 x g, 4 °C). Another 2 ml 5 mM Tris (pH 7.5) containing 
protease inhibitor was added and the centrifugation was repeated. This last step was 
repeated once more, and the now dialyzed and concentrated samples were collected as 
described above. 
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2.6.2.2 Aminopeptidase C assay 
Principle 
The aminopeptidase C assay was used to estimate the level of cytosolic contamination 
in the buffer extracts. Aminopeptidase C is an enzyme that hydrolyses both peptides 
and aminoacyl–p-nitroanilides (Mistou & Gripon, 1998) that is only found in the 
cytosol. By incubating protein extracts with L-arginine-p-nitroanilide any 
aminopeptidase Cs present will hydrolyze the compound and give two products; L-
arginine and p-nitroaniline. p-nitroaniline is a yellow compound with an absorption 
maximum at 410 nm (Mistou & Gripon, 1998). By measuring the reaction 
spectrophotometrically, any absorbance at 410 nm (that is above the present 
background absorbance) will indicate aminopeptidase C activity, and thereby be an 
indication of cytosolic contamination present in the protein extract. The use of this 
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Figure 2.5 The cytosolic protein aminopeptidase C hydrolyses L-arginine-p-nitroanilide into L-
arginine and p-nitroaniline. p-nitroaniline is an yellow compound with absorption maximum at 410 nm. 
 
Procedure 
Fresh protein extracts (10 µl) were added to 188 µl 20 mM Tris (pH 7.5) in a 
microtitrer plate. The plate was incubated at RT for 10 minutes before 2 µl L-
arginine-p-nitroanilide (200 mM in 20 mM Tris (pH 7.5)) was added to each well. The 
absorbance at 405 nm was measured, using a Wallac 1420 Multilabel counter 
(Wallac, Turku, Finland) reader, every fifth minute over a period of 20 minutes. A 
blank containing no protein extract was also analyzed in each run.  
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All the buffer extracts and their respective washes, cytosolic fractions and the 
supernatant containing the extracellular proteins, were analyzed. Whole cell extracts 
were also analyzed. Analysis was performed immediately after harvesting, before any 
concentration or precipitations.  
 
The effect of the different buffers on the assay was investigated. One µl of fresh 
whole cell extract was incubated for 15 minutes with 10 µl of each buffer, as specified 
in table 2.4 and assayed as described above. 
 
2.6.2.3 1-D SDS Polyacrylamide-gel electrophoresis of protein extracts 
In 1-D gel electrophoresis the proteins are separating according to their molecular 
weight. SDS (Sodium dodecyl sulfate) will bind the polypeptide backbone and make 
the proteins negatively charged, thus all proteins will migrate towards the anode with 
speed proportional to each proteins MW. The proteins are denatured by heating and 
disulfide bridges are reduced with 2-mercaptoethanol. 
 
The buffer extracts (listed in table 2.4) and their corresponding total protein fractions 
extracted from the remaining cell pellet after buffer extraction were analyzed by  1-D 
SDS polyacrylamide gel electrophoresis. In addition the wash extract (the supernatant 
after the washing step, see 2.6.2.1) was investigated by SDS PAGE for comparison of 
protein patterns.  
 
Protein samples and Prestained Protein Marker (from New England Biolabs) were 
reduced and denatured by heating at 100 °C for four minutes in 5X sample buffer in a 
4:1 relationship. The 5X sample buffer contains; 0.6 ml 1 M Tris-HCl (pH 6.8), 5 ml 
50 % (v/v) glycerol 2 ml 10 % (w/v) SDS, 0.5 ml 2-mercaptoethanol, 1 ml 1 % (w/v) 
bromophenol blue, and 0.9 ml dH2O.  
 
SDS PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) was 
performed on the Bio-Rad Mini Protean II system. A 10 % separating gel was 
prepared by mixing: 
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5 ml 40 % (w/v) acrylamide 
5 ml separating buffer (75 ml 2 M Tris (pH 8.8), 4 ml 10 % SDS, and 21 ml dH2O) 
10 ml dH2O 
100 µl 10 % (w/v) ammonium persulfate 
10 µl TEMED (N,N,N',N'-tetramethylethylenediamine) 
 
The solution was gently mixed and poured in the gel casting chamber. ~2 mm dH2O 
was gently layered on top to make an even surface. The gel was polymerized for ~45 
min at RT. 
 
A stacking gel was prepared by mixing: 
0.5 ml 40 % (w/v) acrylamid 
1.0 ml stacking gel buffer (50 ml 1 M Tris (pH 6.8), 4 ml 10 % SDS, and 46 ml dH2O) 
2.5 ml dH2O 
100 µl 10 % (w/v) ammonium persulfate 
10 µl TEMED 
 
Excess water on top of the gel was removed and the stacking gel was poured on top. 
A comb was inserted and any air bubbles were removed. The gel was polymerized for 
~30 min at RT. 
 
The gel was placed in the gel chamber and the chamber was filled with PAGE 
running buffer (3 g Tris, 14.4 g glycin, 1 g SDS, dH2O to a total volume of 1 liter). 
Protein samples and marker were loaded and electrophoresis was carried out at 110 V 
for ~100 min.  
 
The gels were stained with Coomassie Brillant Blau R-250 (AplliChem, Darmstadt, 
Germany). CBB R-250 (1.0 g) was mixed in 450 ml dH2O, 450 ml methanol and 
100ml glacial acetic acid to make the gel staining solution. Each gel was stained in 
this solution for ~10 minutes under agitation. The gels were destained ON with 
destaining solution (100 ml methanol, 100 ml glacial acetic acid and 800 ml dH2O). 
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2.6.3 Investigation of protein expression patterns 
2.6.3.1 Shift experiment and protein isolation 
The LiCl extraction buffer (1.5 M LiCl in 20 mM Tris (pH 7.5) containing protease 
inhibitor) was selected for the protein extractions in the following experiments. Shift 
experiments were performed as described in section 2.2.7 with some exceptions; 1) 
the mucin culture was not used. 2) Samples were taken at 30 minutes after the shift 
for control, bile and bile salts cultures and immediately after the shift for the control 
only. 3) The entire cultures (200 ml) were harvested.  
 
The protein extraction was performed as described for the LiCl extraction described in 
section 2.6.2.1. In brief; the culture was harvested by centrifugation, washed and 
suspended in 1.5 M LiCl in 20 mM Tris (pH 7.5) containing protease inhibitor, 
incubated for 15 min on ice and the proteins in the supernatant were harvested. The 
experiments were done in three parallels. The protein yield of buffer extracts for the 
control culture at 0 minutes (A0) and the bile culture at 30 minutes (B30) were low. 
The proteins from two parallel extractions were therefore combined in order to 
increase protein yield. The LiCl extracts were analyzed by the aminopeptidase C 
assay (2.6.2.2), concentrated and dialyzed (see section 2.6.2.1). The protein 
concentrations were measured and 5 µg of each extract was subjected to analysis by 
2-D electrophoresis 
 
2.6.3.2 Two-dimensional electrophoresis 
Principle 
2-DE is a method for separation of proteins in two dimensions on a gel. In the first 
dimension the proteins is separated according to each proteins isoelectric point (pI) by 
isoelectric focusing. In the second dimension the proteins are separated according to 
their mass. 
 
Procedure, isoelectric focusing 
IsoElectric Focusing (IEF) was performed on 7 cm pH 3- 10 NonLinear IPG strips 
(Invitrogen (ZOOM® strip pH 3 – 10 NL)) and run in the ZOOM® IPGRunner™ 
MiniCell (Invitrogen).  
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For each sample, 5 µg protein in a total of 34 µl ddH2O was mixed with 116 µl 1.33X 
rehydration solution (4.2 g urea, 1.52 g thiourea and 0.4 g Chaps and a trace of 
bromophenol blue in 7.7 ml ddH2O) to give 5 µg proteins in a total of 150 µl 1X 
rehydration solution (7 M urea, 2 M Thiourea and 4 % (w/v) Chaps). The entire mix 
(150 µl) was loaded into the ZOOM® IPGRunner™ cassette and IPG strips were 
inserted. The cassette was sealed and the strips were rehydrated for 2 hours. The 
sealing tape was removed, dH2O was added to the electrode wicks and IEF was 
performed according to the program shown below. Four to six samples were focused 
in each run.   
 Step 1:  100 V, 20 min 
 Step 2:  200 V, 15 min 
 Step 3:  450 V, 15 min 
 Step 4:  750 V, 30 min 
 Step 5:  1500 V, 30 min 
 Step 6:  3000 V, 120 min 
 




The focused IPG strips (7 cm, pH 3- 10NL) were equilibrated in 10 ml equilibration 
solution (6 M urea, 30 % (v/v) glycerol, 2 % (w/v) SDS 75 mM Tris (pH 8.8) and trace 
of  bromophenol blue) and 100 mg DTT at RT under gentle shaking for 15 minutes in 
order to reduce any oxidized proteins. The equilibration solution was removed the 
strips were incubated at RT with gentle shaking for 15 minutes in 10 ml equilibration 
solution containing 250 µg iodoacetamide in order to carbamidomethylate free sulfur 
groups (and remaining DTT) and thus prevent formation of new disulfide bonds. 
 
The IPG strips were then loaded onto 4 -12 % Bis-Tris gels (NuPAGE® Novex 4-12% 
Bis-Tris ZOOM® Gels, 1.0 mm. Invitrogen) and  ~400 µl hot 0.5 % (w/v) agarose, 
with a trace of bromophenol blue, was added to the well on top of the strip. 
Electrophoresis was performed in 1X MOPS buffer (Invitrogen) at 200 V for ~75 
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minutes (until the bromophenol blue left the gels). The gels were immediately placed 
in fixing solution (see silver staining below). 
 
Silver staining 
Silver staining of 2-D gels was carried out with a method based on the Amersham 
Biosciences PlusOne Silver Stain Kit. This method is compatible with MS analysis. 
 
All water used for washing and the staining solutions was Milli-Q water (18.2 MΩ 
dH2O, Millipore, here; abbreviated ddH2O) and all solutions were freshly prepared.  
The gels were under gentle agitation throughout the procedure and all solutions were 
removed by aspiration. The protocol described below was followed: 
 
1)  The gels were fixed for 30 min or ON in fixation solution (100 ml ethanol, 125 
ml ddH2O, and 25 ml glacial acetic acid.)  
2)  Sensitizing was performed for 30 min in sensitizing solution (75 ml ethanol, 
10 ml 5 % (w/v) sodium thiosulfate, and 17 g sodium acetate in total 250 ml 
ddH2O.) 
3)  The gels were washed gels 3 x 5 minutes in ddH2O 
4)  Staining was performed in 0.25 % (w/v) silver nitrate for 20 minutes 
5)  The gels were additionally washed for 2 x 1 minute 
6)  Developing was performed by adding developing solution until the solution 
becomes brownish (10 – 30 sec.) The developing solution was removed and 
fresh developing solution was added. The gels were allowed to develop for 2-5 
minutes, until a known pattern became visible. To make developing solution 
10.6 g potassium carbonate and 50 µl formaldehyde was mixed in 250 ml 
ddH2O. 
7)  The reaction was stopped by adding stop solution (3.65 g Na2EDTA·2H2O in 
250 ml ddH2O) and agitation for ~10 minutes. 
 
Stained gels were kept in ddH2O. 
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2.6.3.3 Analysis of expression pattern on 2-DE gels 
Expression patterns detected by 2-D electrophoresis were analyzed using 
ImageMaster™ 2DE Platinum 6.0 software from GE healthcare. Pictures of the gels 
were taken to 16 bits images. The gels were normalized, grey levels/contrast was 
adjusted and spots were detected. The spots were quantified using the relative volume 
(vol %), meaning that each spot is presented as the volume % of the total spot volume 
in the entire gel. For each treatment and time-point (A0, A30, B30 and C30) three gels 
(each from a different biological replicate) were matched together (in match-sets; A0, 
A30, B30 and C30). For ease of comparison synthetic gels were made for each match-
set based on the average volume % of the matched spots.  
 
The spots from all the match-set were then matched to each other. Spots that 
displayed different regulation in B30 and/or C30 when compared to A0 were selected. 
These spots were then filtered by; (1) removing spots that had an internal standard 
deviation (between the replicates in the match-set) that overlaid with the standard 
deviation of the matching spot in A0. (2) Removing spots that showed a similar 
regulation in A30 and (3) filtering out compared spots that had a log2 ratio between 
0.59 and -0.59. All spot regulations were in addition confirmed by visual comparison. 
 
2.6.4 Identification of proteins; Protein mass fingerprinting 
Principle 
Protein Mass Fingerprinting (PMF) is a method for the identification of proteins. 
Excised protein spots are digested to give peptides for which the masses are 
determined by MS. A comparison is made to the peptide masses with all possible in 
silico digested peptide masses in a database: The mascot program used for PMF will 
take all theoretical proteins in the specified database (here: NCBInr) and generate all 
potential peptide masses if these proteins were digested with a specified protease 
(here: trypsin). The theoretical masses of these peptides are then compared to the 
masses obtained for trypsin digested proteins of interest.  
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2.6.4.1 Trypsin digestion  
Protein spots of interest were cut out of the gels using pipette tips and kept at -20 °C 
until the day of analysis. Milli-Q water (ddH2O) was used in all steps. Eight spots, 
four from B30 and four from C30 were excised and analyzed by Protein Mass 
Fingerprinting (PMF).  This was done in two parallels, with each parallel spot located 
on parallel gels 
 
The gel spots were destained in farmers reducing agent (5 % (w/v) sodium thiosulfate/ 
0.25 % (w/v) freshly prepared potassium ferracyanide, ) until the samples were color 
less (~10 minutes). Samples were then washed 2 x 20 minutes in 20 mM ammonium 
bicarbonate/ 50 % (v/v) acetonitrile and washed once for 5 minutes in 100 % 
acetonitrile. The gel pieces were dried in a SpeedVac for 30 minutes. Fifteen µl 0.02 
µg/µl trypsin (Sequencing Grade Modified Trypsin from Promega (Madison, WI, 
USA)) in 20 mM ammonium bicarbonate was added and the gel pieces were allowed 
to swell for 15 minutes. Excess liquid was removed and 20 mM ammonium 
bicarbonate was added until it covered the gel pieces (10 – 20 µl). Digestion was 
performed ON (~18 h.) at 37 °C. The liquid was removed and kept on ice until MS 
analysis. The gel pieces were washed twice with shaking in 20 µl 0.2 % (v/v) TFA 
(Trifluoroacetic Acid) for 45 min on 37 °C. The washes were harvested and 
combined.  
 
2.6.4.2 MALDI-TOF analysis of trypsin digests 
MALDI-TOF MS (Matrix Assisted Laser Desorption Ionization – Time of Flight 
Mass spectrometry) was used to identify the trypsin digests and was performed on a 
Voyager – DE™ RP BioSpectrometry™ Workstation Mass spectrometer from 
PerSeptive Biosystems inc. (Houston, Texas, USA).  
 
An α-cyano-4-hydroxycinnamic acid matrix was used. This was prepared by mixing 
10 µg α-cyano-4-hydroxycinnamic acid in 1 ml 50 % acetonitrile/0.1 % (v/v) TFA. 
The solution was vortexed for 1 minute and centrifuged at 13000 rpm for 30 seconds. 
500 µl of the supernatant was collected, combined with 500 µl 50 % acetonitrile/0.1 
% (v/v) TFA and 24 µl 5 mg/ml ammonium citrate was added.  
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The trypsin digested protein samples, (1 µl) of each sample, were spotted on the 
MALDI-plate and 0.6 µl matrix was added to each spot. The peptide/matrix mix was 
air-dried and the MALDI-plate was inserted into the MS. The mass-spectra were 
recorded in Voyager Instrument Control Panel (version 5.10) software from Applied 
biosystems. Three spectra of each 80 shots were combined for each sample. Spectra 
were recorded for masses ranging from 1 kDa to 4 kDa only because of a very high 
noise level in the lower part (700 – 1000 Da) of the spectra. The spectra were baseline 
correlated and the noise was removed with the Data Explorer version 4.0.0.0. 
software. The mass list was exported to the Mascot program. 
 
2.6.4.3 Identification of digested proteins 
Peptide masses were detected with the Mascot program, available at 
http://www.matrixscience.com. The peptide masses were queried against the NCBInr 
(non-redundant) database, with trypsin as the digestion enzyme, carbamidomethyl as 
fixed peptide modification, and oxidation of methionine as a variable peptide 
modification. Monoisotopic masses were used and the peptide tolerance was set to 
±1.0 Da. Only peptides with a MOWSE-score above the cut-off were used and each 
identified peptide was also confirmed by matching its theoretical mass and pI with its 
localization on the gel. 
 
2.7 Practial Proteomics in York 
In April 2005 I attended to the Practical Proteomics course I at University of York. In 
this course my own protein extracts and excised gel bands were analyzed. In addition 
the 2-DE separation of an E. coli protein extract, on the Invitrogen Mini gel system, 
was demonstrated.  
 
The following work was carried out: The protein sample was a combination of two 
CTAB extracts (as described in 2.6.2.1). This was concentrated and ~60 µg was 
diluted in 350 µl rehydration solution, applied to 18 cm 3-10 linear IPG strips 
(Immobiline DryStrip, Amersham) and rehydrated ON. IEF was performed with the 
following program; 300 V for 6 min, gradient V-increase to 3500 V in 3 hours, 3500 
V for 3 hours, 8000 V for 64000 Vh. The strip was equilibrated, reduced, 
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carbamidomethylated and applied to a 9 – 16 % gradient gel. Electrophoresis was 
carried out at 200 volt for   ~6 hours. The gel was silver stained as described in 
2.6.4.3.  
 
The excised 1-D bands are indicated in figure 3.19 (bands named A, B, and C). These 
were destained, equilibrated as the IPG strips (section 2.6.4.2), and digested as 








3.1 Bacterial growth and shift experiments 
3.1.1 Growth, pH and glucose concentration curves 
Bacillus cereus ATCC 14579 growth, pH and glucose concentration curves are shown 
in figure 3.1. 100 ml IR-medium was inoculated with one batch of ON-culture in a 1 
L Erlenmeyer flask and incubated at 37 °C and 175 rpm. Samples were taken every 
hour. The cell density was measured by flow cytometry, pH was measured with pH 
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Figure 3.1 Bacteria cell density, pH and [glucose concentration] during growth of Bacillus cereus 
ATCC 14579 in IR-medium. The data represents the mean of at least two experiments, and the error 
bars indicate standard deviation. 
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3.1.2 Survival of B. cereus ATCC 14579 in bile and bile salts 
B. cereus was grown in the presence of different concentrations of bile and bile salts 
in order to select appropriate concentrations to be used in shift experiments. The 
results are shown in figures 3.2 and 3.3. On the basis in these results; concentrations 
of 0.03 % (w/v) and 0.005 % (w/v) of bile and bile salts respectively, were selected 
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Figure 3.2 Growth of Bacillus cereus ATCC 14579 in medium containing different concentrations of 
bile. The start culture was divided into four portions after 3 hours of growth and bile was added to the 
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Figure 3.3 Growth of Bacillus cereus ATCC 14579 in medium containing different concentrations of 
bile salts. The start culture was divided into four portions after 3 hours of growth and bile salts were 




3.1.3 Bile salts adaptation test 
Exponentially growing B. cereus ATCC 14579 was shifted to new media containing 
bile salts, (0.005 % final concentration, w/v) and incubated for 5 minutes before 
samples were plated out on LB-agar plates containing different concentration of bile 
salt. No colonies were observed on plates containing more than 0.01 % bile salts after 
ON incubation. Incubation for a further three days did not give any new colonies. The 
same results were obtained after preincubation of B. cereus with 0.005 % bile salts for 
30 min. The results are shown in table 3.1 which includes, cell densities at point of 
harvest, number of bacteria plated out, and number of bacteria colonies observed in 
the different concentration of bile salt and the percent survival. 
 
Table 3.1 Results of test for adaptation of B. cereus ATCC 14579  to bile salts. Exponentially growing  
B. cereus cultures were shifted to media containing 0.005 % bile salt, and incubated for 5 or 30 minutes 
before plated out on LB-agar plates containing different concentration of bile salt. A control culture 
which shifted to media without bile salts were also plated out. The average cfu and st.dev results are 
from three plates of the same culture. The cfu number and st.dev. in the control plates results from a 
10X dilution - the numbers counted was 1/10th. 
Control – 0 % bile salts Survival in bile salts 
  
# bacteria plated 
out 
0.001-0.005 %   
bile salts  0.01 % bile salt 








average   
# cfu st.dev # cfu 
average 
# cfu st.dev 
Percent 
survival # cfu  
Bile salts 
0.005 % - 5 




0.005 % - 5 




0.005 % - 




0.005 % - 
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3.1.4 Growth of Bacillus cereus ATCC 14579 in shift experiments 
Growth and pH curves for Bacillus cereus ATCC 14579 grown in IR-medium and 
shifted to IR-medium containing; no additives (control), 0.03 % (w/v) bile, 0.005 % 
(w/v) bile salts and 0.25 % (w/v) mucin are given in figure 3.4 and 3.5. The cell 
density, measured by flow cytometry, and the pH were determined at the times 
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Start culture Cell #/ml
A control  Cell #/ml
B 0.03 % bile Cell #/ml
C 0.005 % bile salts Cell #/ml
D 0.25 % mucin Cell #/ml
Start culture pH
A control pH
B 0.03 % bile pH
C 0.005 % bile salts pH
D 0.25 % mucin pH
 
Figure 3.4 After 3 hours the start culture was shifted to new growth media containing 100 ml IR-
medium and; A no additives  (control), B bile 0.03 %, C bile salts 0.005 %, D mucin 0.25 % (all w/v, 
final concentrations). The cultures were grown at 37 ° and 175 rpm. The error bars indicate the 
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B 0.03 % bile
C 0.005 % bile salts
D 0.25 % mucin
 
Figure 3.5 The 45 minutes time-window after the cultures were shifted to new growth media. This is 
not included in the previous figure (fig 3.4). The dots represent the average of at least 3 different 
experiments. The standard deviation is left out for the sake of clarity. Note that the scale is not 
logarithmic.  
 
3.2 In silico identification of candidate virulence genes 
3.2.1 Candidate virulence genes in B. cereus ATCC 14579 
To identify candidate virulence genes three criteria for selection were defined; 
involved in pathogenesis/host cell adhesion, associated with the cell wall, and 
possibly regulated in intestine. A number of genes satisfying these 3 criteria are 
shown in table 3.2. The genes are selected on basis of their NCBI annotation, their 
documented function, their similarity to known domains, and/or by their similarity to 
well investigated genes in other gram positive bacteria investigated with blastp or 









Table 3.2 Candidate virulence genes in Bacillus cereus ATCC 14579 which are associated with the cell 
surface. 
BC 




Similar gene in L. monocytogenes and 




Similar gene in L. monocytogenes and 
Streptococcus spp. Known virulence factor See above. 
BC 0552 Internalin A 
NCBI-annotation / Well known virulence 
factor in L. monocytogenes / similarity (Cossart et al., 2003) 
BC 1331 Internalin A 
NCBI-annotation / Well known virulence 
factor in L. monocytogenes / similarity See above. 
BC 1101 Internalin G? 
NCBI-annotation / Well known virulence 
factor in L. monocytogenes / similarity See above. 
BC 4948 Internalin G? 
NCBI-annotation / Well known virulence 
factor in L. monocytogenes / similarity See above. 
BC 4868 Camelysin NCBI-annotation / Documented toxin (Grass et al., 2004) 
BC 1281 Camelysin NCBI-annotation / Documented toxin (Grass et al., 2004) 
BC 5135 Enolase 
Virulence factor in Streptococcus spp / 
similatrity 
(Pancholi & Fischetti, 
1998) 
BC 2952 
Cell wall binding 
protein, enterotoxin NCBI-annotation / SH3 domain  
BC 0813 
Cell wall binding 




NCBI-annotation / similarity with CW-




NCBI-annotation / similarity with CW-




NCBI-annotation / similarity with CW-




NCBI-annotation / similarity with CW-




NCBI-annotation / similarity with CW-
genes in other B. cereus strains  
BC 3526  
Collagen adhesion 
protein 
NCBI-annotation / similarity with CW-




NCBI-annotation / similarity with CW-
genes in other B. cereus strains  
BC 3529 
Microbial 
collagenase NCBI-annotation  
BC 0556 
Microbial 
collagenase NCBI-annotation  
BC 2466 
Microbial 
collagenase NCBI-annotation  
BC 3161 
Microbial 
collagenase NCBI-annotation  
BC 3762 
Microbial 
collagenase NCBI-annotation  
BC 3009 
Microbial 
collagenase NCBI-annotation  
BC 3010 
Microbial 






Fibronectin binding protein 
A needleman-wunch global alignment with BLOSUM62 matrix was preformed 
between the fibronectin binding protein of L. monocytogenes EGD-e strain and 
Bacillus cereus ATCC 14579. 50 % of the sequences are identical and 70 % are 
similar. The alignment between the sequences is given in figure 3.6 
 
An Interpro scan also reveals that the two fibronectin binding proteins (BC3873 and 
BC1771) have a fibronectin binding domain (Pfam, accession number: PF07299, 
(Christie et al., 2002; Gilot et al., 1999)). However the fbp proteins do not have a 




Figure 3.6 Needleman-Wunch global alignment of Listeria monocytogenes EGD-e and Bacillus cereus 









The internalin A genes in Bacillus cereus ATCC 14579 have ~23 % identity and ~36 
% similarity with the internalin A genes of L. monocytogenes EDG-e strain 
(Needleman-Wunch global alignment, not shown). Both BC1331 and BC0552 have 
several leucine rich repeats (Pfam, Accession number: PF00560). BC0552 has a 
LPXTG motif (HMMTigr, accession number: TIGR01167; Pfam, accession number: 
PF00746) for covalently linking to peptidoglycan (Ton-That et al., 2004) and BC1331 
has a s-layer homology domain (Pfam, accession number: PF00395; Prosite, 
accession number: PS01072). BC1331 has in addition an internalin domain 
(panther.appliedbiosystems.com; accession number: PTHR10588:SF3). BC1331 also 
has a IMP dehydrogenase / GMP reductase domain (Pfam, accession number: 
PF00478 (Zhang et al., 1999)) 
 
The two internalin G sequences both have leucine rich repeats (Superfamily HMM 
library, accession number: 52058) and prove similar to internalin G domains (ProDom 
family, accession number: PD696974) 
 
Enolase 
Apart from their well investigated function in glycolysis enolases are often surface-
associated and involved in binding to plasminogen (see discussion). The enolase gene 
scores positive to enolase-domains, but not surface-localization or plasminogen-
binding (data not shown). Similar results were also obtained for enolases of the other 
species listed below. In figure 3.7 below is a multiple alignment of enolases from 
Staphylococcus aureus N315, Streptococcus pneumonia TIGR4, Streptococcus 
pyogenes M1 GAS, Listeria monocytogenes EGD-e, and B. cereus ATCC 14579. A 
Needleman-Wunch global alignment (BLOSUM62) reveals 75 % identical and 84 % 
similar amino acids residues of the enolases from B. cereus ATCC 14579 (BC5135) 




Figure 3.7 Multiple alignment of enolases from different gram positive bacteria. The bacteria strains 
are listed in the text above. The genes’ locus tags are: sp1128, spy0731, sa0731, bc5135 and lmo2455, 
respectively. Red color: identical amino acid. Green color similar: amino acid. 
 
3.3 RNA isolation and PCR primer testing 
3.3.1 RNA isolation 
Total RNA was isolated from the four cultures in the shift experiment (A – control, B 
– bile, C – bile salts and D – mucin). Samples for RNA isolation were taken at 0 – 5 – 
10 – 20 and 30 minutes after the shift. The RNA from two different shift experiments 
was isolated by the FastPrep® - method. The RNA concentrations and protein 
contaminations were estimated spectrophotometrically by measuring the A260nm and 
the ratio A260nm/A280nm. Total RNA concentrations varied between 0.31µg/µl and 1.66 
µg/µl, giving a yield of, from 31 µg RNA to 166 µg RNA. The A260nm/A280nm – ratio 
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varied between 1.5 and 2.2 with most of the samples in the range 1.6 – 1.8. The 
concentrations and the A260nm/A280nm – ratio are given in table 3.3 
 
Table 3.3 Total RNA concentrations and A260nm/A280nm – ratio of RNA isolated from two different shift 
experiments. The letters indicate the different shift cultures (A – control, B – bile, C – bile salts and D 
– mucin), and the numbers indicates the time in minutes after the shift. 










A0 1.6 0.41 1.7 0.48 
A5 1.6 0.52 1.7 0.47 
A10 1.6 1.04 1.7 0.48 
A20 1.6 1.24 1.7 0.53 
A30 1.6 1.01 1.5 0.73 
B0 1.6 0.76 1.6 0.37 
B5 1.6 0.56 1.8 0.23 
B10 1.6 0.64 1.7 0.40 
B20 1.6 0.31 1.7 0.73 
B30 1.6 0.63 1.7 0.64 
C0 1.6 0.66 1.8 0.58 
C5 1.6 0.84 1.9 0.68 
C10 1.6 1.02 2.1 0.57 
C20 1.6 0.92 2.2 1.06 
C30 1.6 1.66 2.0 0.59 
D0 1.6 0.47 1.8 0.43 
D5 1.6 0.80 1.7 0.62 
D10 1.6 0.77 1.8 0.70 
D20 1.6 0.78 1.5 1.12 
D30 1.6 1.31 1.8 0.60 
 
 
The integrity of the isolated RNA was checked by electrophoresis on formaldehyde 
agarose gels and detection by ethidium bromide staining. With the exception of the 
mucin-containing samples, most of the samples have two intact rRNA bands and 
minimal DNA contamination. A picture of the gels is shown in figure 3.8. Only 




Figure 3.8 Integrity of RNA investigated by electrophoresis. The pictures show formaldehyde agarose 
gels of total RNA samples from two parallel experiments. The 23S and 16S rRNA bands are clearly 
visible and DNA contamination is minimal for most samples. L = RNA ladder, A = control, B = bile, C 
= bile salts and D = mucin. The number following each letter indicates how many minutes after the 
shift the RNA is isolated. 
 
3.3.2 Testing of PCR primers 
Oligonucleotide primers were designed with eprimer3, and synthesized by MWG. The 
sequences are given in table 2.2 in the methods section. 
 
Three genes were, fbp, intA and intB, selected for investigation of mRNA levels as 
estimated by RealTime RT PCR analysis. The reference gene selected was gap. The 
primers for these four genes were tested on Bacillus cereus ATCC 14579 genomic 
DNA template. All the selected primers were found to be function and gave PCR 
products of correct size (~200 bp) as estimated by agarose gel electrophoresis. A 
picture of the agarose gel after electrophoresis and ethidium bromide staining is given 






Figure 3.9 Picture of an etidium bromide stained agarose gel showing the results of PCR primers 
testing. The primers were tested on Bacillus cereus ATCC 14579 genomic DNA template. From left 
are (1) 1 kb ladder, (2) intA, (3) intB, (4) fbp and (5) gap. The primer sequences is given in table 2.2 
 
3.4 Expression patterns investigated by real-time PCR 
3.4.1 Reference gene 
The expression pattern of the selected reference gene, gap, was investigated to see if it 
was equally expressed throughout the time window (0 to 30 minutes) of the shift 
experiment. With the exception of D0 (and to some degree C0) the changes in the 
expression levels are minimal.  The expression changes (2-ΔCt) for 10-1 dilutions of the 
specified samples are shown in table 3.4 below. 
Table 3.4 Expression changes in the reference gene, gap.  A0 is used as reference and set to 1. 
Sample Ct-value 2
-ΔCt             
(ΔCt = CtA0 - Ctsample) 
A0 15.04 1 
A30 13.42 0.65 
B0 13.99 0.97 
B5 13.62 0.75 
B10 13.91 0.91 
B30 14.13 1.06 
C0 16.01 3.91 
C30 13.68 0.80 
D0 20.78 106 
D30 14.89 1.80 
 
3.4.2 Amplification efficiencies of gap, fbp, intA, and intB 
The amplification efficiencies were determined for each target sequence and the 
results are given in table 3.5.  
 
200 bp
1 2 3 4 5
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The Ct-values of each target sequence was plotted against log 10 of the dilution and a 
regression line was calculated. Based on the slope of each line, the amplification 
efficiencies were calculated; see section 2.5.1 (7). At least 5 different regression lines 
were used for each target sequence amplification was calculated for each regression 
line. The average amplification efficiencies were used. Figure 3.10 a – d shows the 
regression lines of the selected genes (fbp, intA, intB, and gap). All Ct-values, both 
for amplification efficiencies and relative quantification can be found in appendix III. 
 






gap 1.04 0.026 
fbp 0.99 0.035 
intA 1.03 0.076 
intB 1.02 0.049 
 
 
gap -  Regression lines
(A0)
y = -3.174x + 10.89
R2 = 0.9985
(B5)
y = -3.32x + 10.364
R2 = 0.9993
(B10)
y = -3.164x + 10.76
R2 = 0.9995
(B30)
y = -3.222x + 10.922
R2 = 0.9976
(D30)
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Figure 3.10a Regression lines for intB. RNA samples used are indicated in the figures. The regression 
lines are calculated using the least square method. The amplification efficiencies are calculated from 




fbp - Regression lines
(D30)
y = -3.328x + 16.966
R2 = 0.9922
(C0)
y = -3.356x + 16.556
R2 = 0.9935
(C30)
y = -3.254x + 17.375
R2 = 0.9996
(A30)
y = -3.43x + 16.292
R2 = 0.9993
(A0)
y = -3.454x + 16.226
R2 = 0.9988
(D0)
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Figure 3.10b Regression lines for fbp. RNA samples used are indicated in the figures. The regression 
lines are calculated using the least square method. The amplification efficiencies are calculated from 
the absolute value of the slope. 
 
intA  - Regression lines
(D0)
y = -3.0583x + 23.966
R2 = 0.9989
(C30)
y = -3.5194x + 20.904
R2 = 0.9985
(B30)
y = -3.314x + 19.182
R2 = 0.999
(C0)
y = -3.078x + 17.701
R2 = 0.9955
(B0)
y = -3.24x + 19.396
R2 = 0.995
(A0)
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Figure 3.10c Regression lines for intA. RNA samples used are indicated in the figures. The regression 
lines are calculated using the least square method. The amplification efficiencies are calculated from 
the absolute value of the slope. 
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intB - Regression lines
(D0)
y = -3.4034x + 19.759
R2 = 0.9972
(C0)
y = -3.4349x + 15.117
R2 = 0.9971
(B30)
y = -2.95x + 18.854
R2 = 0.9977
(A30)
y = -3.244x + 18.298
R2 = 0.9953
(D0)
y = -3.1234x + 19.019
R2 = 0.9966
(C5)
y = -3.384x + 16.24
R2 = 0.998
(D30)
y = -3.196x + 18.202
R2 = 0.9944
(A30)
y = -3.244x + 18.298
R2 = 0.9953
(A20)
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Figure 3.10d Regression lines for intB. RNA samples used are indicated in the figures. The regression 
lines are calculated using the least square method. The amplification efficiencies are calculated from 
the absolute value of the slope. 
 
3.4.3 Relative quantification of gene expression 
The Plaffl-method (section 2.4.4.3) was used to calculate the relative expression of 
intA, intB and fbp, when exponentially growing Bacillus cereus ATCC 14579 was 
shifted from IR medium to IR media with no additives or IR-media containing bile, 
bile salts and mucin (section 2.2.7). Figure 3.11 to 3.13 shows the differences in 
expression for each gene 0 – 30 minutes after the shift. A0 (the control immediately 
after the shift) is set as a reference to 1. All other samples are expressed as the fold 
changes compared to A0. The fbp sequence gave no significant changes due to the 
shift in the first experiment and further work was not carried out. IntB is down-
regulated in the bile salts shift experiment. This gene was therefore investigated in 2 
or 3 parallels. The control (A) and bile salts (C) were analyzed 3 times, in which one 
of the analysis was performed on RNA from the two different shift experiments. 
These samples were also investigated at 5 and 20 minutes after the shift. IntA also 






























Figure 3.11 Expression pattern of fbp during shift experiment. All samples are expressed relative to A0, 
in which the expression is set to 1. The letter indicates the different additives (A – control, B – bile, C – 





























Figure 3.12 Relative expression pattern of intA during shift experiment. All samples are expressed 
relative to A0, in which the expression is set to 1. The letter indicates the different additives (A – 
control, B – bile, C – bile salts and D – mucin); the following number indicates the time in minutes 


































Figure 3.13 Relative expression pattern of intB during shift experiment. All samples are expressed 
relative to A0, in which the expression is set to 1. The letter indicates the different additives (A – 
control, B – bile, C – bile salts and D – mucin); the following number indicates the time in minutes 
after the shift. The bars indicate the average of two or three experiments; the error bars indicate the 
standard deviation. 
 
3.4.4 Verification of RealTime PCR products 
The melting curves showed a distinct melting temperature (Tm) for each product that 
was specific to that product. The Tm had a range maximum of 1.0 °C, and all parallel 
samples fitted this in this range. No additional peaks (indicating primer dimers, 
chimerical products etc.) were observed.  The menting temperature is given in table 
3.6. 
Table 3.6 Melting temperatures of real-time PCR products. All PCR products fitted in each sequence’ 
range. 
Target sequence Tm (range) 
gap 80.2 – 81.1 ºC 
fbp 79.9 – 80.9 ºC 
intA 77.3 – 78.3 ºC 




The PCR products were subjected to agarose gel electrophoresis and the results 




Figure 3.14 Picture of etidium bromide stained agarose gel of RealTime PCR products, from left to 
right;  L = 100 bp ladder, lane 1: intA, lane 2: intB, lane 3: fbp, lane 4: gap, lane 5: intB (Ct = 24.33), 
lane 6: gap (Ct = 13.33). Note that the intensity of the two differently expressed products (lane 6 and 7) 
are fairly identical. 
 
3.5 Microarray analysis 
3.5.1 RNA isolation and hybridization 
Control RNA samples were isolated immediately after a shift to medium containing 
no additives (A0) and after 30 minutes incubation (A30). Samples of RNA were 
isolated 30 minutes after the shift to medium containing bile or bile salts (B30 and 
C30), see section 2.2.7. The RNA integrity and possible DNA contamination was 
investigated by formaldehyde gel electrophoresis and found suitable (data not shown.) 
All samples (A30, B30, and C30) were hybridized against the control at 0 minutes 
(A0) on microarrays of the B. cereus ATCC 14579 genome. All runs were done in 
two biological replicates. The data was analyzed with using a script written in R 2.0.1. 
by K. Fægri at the institute of pharmacy, Oslo University. 
 
3.5.2 Microarray and expression pattern 
The results from the microarray analysis, expressed as the log2 ratios and P-values of 
each sample against A0 are shown in table 3.7. All signals that had a log2 ratio over 
±0.59 and a P-value below 0.05 for B30 and C30 against A0 are listed in the table. All 
of these signals that also were present in the A30/A0 hybridization and had a P-value 




over 0.05 are included in the list. There were some problems in the second 
hybridization of A30/A0 and C30/A0 which caused low signal intensity. Therefore 
C30/A0 is represented by only one biological replicate. Since the P-value is based on 
the number of observations this led to higher P-values and the use of only one 
replicate in the A30/A0 hybridization gave only a few significant observations. The 
A30/A0 is therefore represented by two biological replicates, but many of the genes 
seen in B30/A0 (and C30/A0) are missing.  The groups of genes listed are based on 
KEGGs putative functions. Some of the genes can belong to more than one group; 
however, they are only listed once.  
 
Several genes are regulated in the bile and bile salts treated cultures, but not in the 
control. The vast majority of genes regulated fall into categories such as metabolism, 
transcriptional regulators, stress response, and transport. See discussion for details. 
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Table 3.7 Section of the microarray results. The A30, B30, and C30 samples were each hybridized against the A0 sample. The log2 ratios and 
the P-values are listed. The complete list is given in appendix IV. Please note that this is a section only, and the complete list should be 
examined to get a better overview. 
  A30/A0 B30/A0 C30/A0 
BC # Genename 
Log2 




ratio  P-value 
Transciptional regulators      
BC0518 Transcriptional regulator. Fur family -0.17 0.039 0.97 0.017   
Toxins      
BC3104 Hemolysin BL lytic component L2   -2.31 <0.005   
Stress response       
BC4312 Chaperone protein dnaK 0.89 <0.005 1.38 <0.005  1.17(2) 0.016(2) 
BC0294 Chaperonin. 10 kDa 1.29 <0.005 3.40 <0.005  2.16(2) 0.015(2) 
BC0295 Chaperonin. 60 kDa 0.78 <0.005 2.97 <0.005   
BC5152 ATP-dependent Clp protease. proteolytic subunit ClpP     1.51 0.037 
BC2214 Heat shock protein. Hsp20 family   3.33 0.047   
BC4314 Heat-inducible transcription repressor HrcA     1.89 0.037 
BC4521 Thioredoxin -0.82 0.019 1.24 <0.005   
BC4272 Superoxide dismutase. Mn   0.68 0.007   
Surface  associated         
BC1331 Internalin. putative   -0.58 0.097   
Transport        
BC0962 Drug resistance transporter. EmrB/QacA family     2.80 0.034 
BC4000 Drug resistance transporter. EmrB/QacA family   2.76 <0.005   
BC0596 Heavy metal-transporting ATPase   1.68 <0.005   
BC1948 Hypothetical Multidrug-Efflux Transporter     -0.76 0.044 
Metabolism         
BC3972 Pyruvate dehydrogenase complex E1 component. beta subunit     0.75 0.038 
BC3971 Pyruvate dhg complex E2 - dihydrolipoamide acetyltransferase   -1.00 <0.005   
BC3970 Pyruvate dhg complex E3 - dihydrolipoamide dehydrogenase -0.74(1) 0.239(1) 0.28 <0.005 0.70 0.094 
BC4160 Dihydrolipoamide dehydrogenase      2.34(2) 0.029(2) 
BC0868 Glyceraldehyde-3-phosphate dehydrogenase. NADP-dependent   1.04 0.036   
Genes with bold BC-number are also investigated by RealTime or 2-DE. (1) Genes in the A30/A0 hybridization that is only confirmed with one 
biological replicate. (2) Genes in the C30/A0 hybridization that is confirmed by two biological replicates. 
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3.6 Protein extraction and 2-D protein gel-electrophoresis 
3.6.1. Protein concentration – standard curves 
Two standard curves, using BSA, for protein concentration were determined and are 
shown in figures 3.15 and 3.16. Protein concentrations were determined with the 
formulas indicated in each figure. The 1 µg to 5 µg curve was used when the 
absorbance in the sample was between 0.420 (A595nm ) and 0.600 (A595nm ) and the 5 
µg to 20 µg curve was used when absorbance of the sample was between 0.600 
(A595nm ) and 0.900 (A595nm ). A mean of the two formulas was used for samples giving 
an absorption between 0.580 (A595nm) and 0.620 (A595nm ). 
Standard curve BSA 1 - 5 µg/ml





















Figure 3.15 Standard curve with BSA ranging from 1 µg to 5 µg. Concentrations in protein samples 
were calculated with the formula given in the diagram, where A is the absorbance and x is µg/ml BSA. 
Standard curve BSA 5 - 20 µg/ml





















Figure 3.16 Standard curve with BSA ranging from 5 µg to 20 µg. Concentrations in protein samples 
were calculated with the formula given in the diagram, where A is the absorbance and x is µg/ml BSA. 
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3.6.2 Whole cell proteins 
A whole cell protein extract of exponentially growing B. cereus ATCC 14579 was 
obtained by harvesting the cell by centrifugation at 4000 x g (rcf)., washing the cell 
pellet once in 20 mM Tris (pH 7.5), and resuspending the cell pellet in 20 mM Tris (pH 
7.5) containing protease inhibitor or lysisbuffer (7 M Urea, 2 M Thiourea and 4 % 
(w/v) CHAPS). The cells were then disrupting in a FastPrep® instrument. The proteins 
extracted in 20 mM Tris (pH 7.5) were harvested from cultures with different cell 
densities and some of these were used in the aminopeptidase C assay (see 3.6.3.1).  
 
Both protein extracts was analyzed by 2-D gel electrophoresis. Five µg protein was 












Figure 3.17 a and b 2-DE gel of total protein extract of exponentially growing B. cereus ATCC 14579. 
Proteins were extracted with the FastPrep® method. 5 µg protein was seperated by isoelectric focusing 
(pH 3 – 10) in the first dimension, and separated by MW in the second dimension. The gels were silver 
stained. pH 10 is the to left side of the gels, and pH 3 to the right side. a) Total protein extracted in lysis 
buffer. b) Total protein extracted in 20 mM Tris (pH 7.5).  
 
3.6.3 Test of buffer extracts 
3.6.3.1 Estimation of cytosolic contamination:  aminopeptidase C activity in 
buffer extracts. 
To test if any of the buffers did inhibit the aminopeptidase reaction 1 µl whole cell 
protein extract was incubated for 15 min at RT with 9 µl of the listed buffers (table 




after 20 minutes is given in table 3.8. The CTAB buffer did inhibit the reaction to 
some degree. On the other hand the sample incubated in 1X PBS and 1 M Tris showed 
higher activity. None of the other buffers or the protease inhibitor appeared to 
influence the reaction. 
Table 3.8 Aminopeptidase C activity of whole cell protein extract in selected buffers 
Buffer A -595
20 mM Tris (pH 7,5) without protease inhibitor 0,188
20 mM Tris (pH 7.5) 0,189
1X PBS (pH 7.0)  0,259
1 M Tris (pH 7.4) 0,240
1 M KSCN in 20 mM Tris (pH 7.5) 0,187
0.01 % NP-40 in 20 mM Tris (pH 7.5) 0,197
0.1 % (w/v) CTAB in 20 mM Tris (pH 7.5) 0,145
0.01 % (v/v) Triton X-100 in 20 mM Tris (pH 7.5) 0,192
1.5 M LiCl in 20 mM Tris (pH 7.5) 0,189
 
 
The buffer extracts listed in table 3.7 were tested in the aminopeptidase C assay.  
The culture supernatant and the wash extract (20 mM Tris (pH 7.5)) were also tested. 
For each buffer extraction proteins in the remaining cell pellet were disrupted and 
extracted in 20 mM Tris (pH 7.5) using the FastPrep® method. In table 3.9, shown 
below, the aminopeptidase C activity of each buffer extract is listed together with the 
total protein extract from the remaining cell pellet. Whole cell protein extracts of the 
entire cultures (200 ml) with a cell denstity of 1.3x107 and 9.3x107 cell#/ml were used 
as positive controls. Any increase in absorption over 20 minutes or a final absorption 
deviating more than 10 % (A595 over 0,094) from the negative control was interpreted 
as positive aminopeptidase C activity and consequently cytosolic contamination in the 
sample. By these criteria the culture supernatant and the NP-40 and Triton X-100 









Table 3.9 Aminopeptidase C activity in buffer extracts measured over 20 minutes. The activity is given 
as the absorption at 405 nm. Increase in absorption or absorption after 20 min that are higher than 10 % 
from the negative are considered positive for aminopeptidase C activity. The number in the left column 
corresponds to those given in table 3.8 and figure 3.19. A number followed by (a) indicates the buffer 
extract and a number followed by (b) indicates the total protein extracts from the remaining cell pellet 
after buffer extraction.  
  Minutes incubated: 0 5 10 15 20 
 
Extraction buffer*  
(and negative/positive controls) Abbreviation Absorption A - 595 nm 
 Negative control ** Negative 0.089 0.088 0.086 0.086 0.085 
 Culture supernatant Supernatant 0.098 0.098 0.097 0.097 0.097 
1 20 mM Tris (pH 7.5) (Wash prior to extraction) Wash  0.092 0.091 0.092 0.092 0.092 
2a 1X PBS (pH 7.0) PBS 0.093 0.092 0.092 0.091 0.091 
2b Cytosolic fraction after PBS extraction  0.221 0.246 0.280 0.308 0.340 
3a 1 M Tris (pH 7.4) Tris 0.090 0.090 0.090 0.090 0.090 
3b Cytosolic fraction after Tris extraction  0.339 0.386 0.421 0.471 0.494 
4a 1 M KSCN in 20 mM Tris (pH 7.5) KSCN 0.094 0.093 0.094 0.094 0.094 
4b Cytosolic fraction after KSCN extraction  0.328 0.352 0.370 0.417 0.462 
5a 0.01 % NP-40 in 20 mM Tris (pH 7.5) NP-40 0.117 0.124 0.130 0.134 0.138 
5b Cytosolic fraction after NP-40 extraction  0.193 0.218 0.241 0.274 0.289 
6a 0.1 % (w/v) CTAB in 20 mM Tris (pH 7.5) CTAB 0.093 0.093 0.093 0.092 0.092 
6b Cytosolic fraction after CTAB extraction  0.234 0.261 0.295 0.311 0.338 
7a 0.01 % (v/v) Triton X-100 in 20 mM Tris (pH 7.5) Triton X 0.101 0.100 0.100 0.101 0.102 
7b Cytosolic fraction after Triton X-100 extraction  0.233 0.255 0.291 0.316 0.351 
8a 1.5 M LiCl in 20 mM Tris (pH 7.5) LiCl 0.094 0.093 0.093 0.093 0.093 
8b Cytosolic fraction after LiCl extraction  0.312 0.348 0.381 0.417 0.446 
 Positive control of extract from 1.3*10^7 cell#/ml Positive 1 0.139 0.147 0.153 0.158 0.165 
 Positive control of extract from 9.3*10^7 cell#/ml Positive 2 0.712 0.755 0.784 0.807 0.834 
* All the extraction buffers contain protease inhibitor. 






























Figure 3.18 Aminopeptidase C activity of tested buffer extracts (see table 3.7 above) over 20 minutes. 
The activity is given as the absorption at 405 nm. Increases in absorption or absorption after 20 min 
that deviate more than 10 % from the negative are considered positive for aminopeptidase C activity. 
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3.6.3.2 Extraction buffers effectively measured by: protein yield, aminopeptidase 
C activity and SDS polyacrylamide gel electrophoresis 
Bacillus cereus ATCC 14579 was grown in IR-media for three hours (37 °C, 175 
rpm) and 100 ml culture was shifted to 100 ml fresh IR-media and harvested 
immediately by centrifugation. The cell pellet was washed and resuspended in 
different extraction buffers which are listed below in table 3.8. The bacteria cell 
density at the time of harvesting was measured by flow cytometry and the 
aminopeptidase C assay was performed on fresh extracts. The samples were 
concentrated by ultrafiltration and the protein concentration was measured. A 
summary of the results are found in table 3.10 
 
Table 3.10 Summary of results for testing of extraction buffers. The cell densities at time of harvest, 
protein concentrations, total protein yield, and result of the aminopeptidase C test is given in the table 












1 20 mM Tris (pH 7.5) - Wash step - 1 minute 4.3x107(3) Pass 243(4) 27(4) 
2 1X PBS (pH 7.0)  2.2 x107 Pass 291 29 
3 1 M Tris (pH 7.4) 5.1 x107 Pass 423 51 
4 1 M KSCN in 20 mM Tris (pH 7.5) 6.6 x107 Pass 337 37 
5 0.01 % NP-40 in 20 mM Tris (pH 7.5) 6.1 x107 Fail 2860 286 
6 0.1 % (w/v) CTAB in 20 mM Tris (pH 7.5) 2.9 x107 Pass 324 39 
7 0.01 % (v/v) Triton X-100 in 20 mM Tris (pH 
7.5) 
3.8 x107 Fail 382 42 
8 1.5 M LiCl in 20 mM Tris (pH 7.5) 7.7 x107 Pass 308 28 
(1)All buffers contains protease inhibitor. (2) After concentration of samples.                                                 
The wash step had a rather dense protein concentration, thus three extractions were combined: (3) The 
cell density is the mean of three extractions. (4) The protein yield are from three combined extractions 
(washes.) 
 
SDS-PAGE was performed with 20 µl of the concentrated buffer extracts and 5 µl of 
the total protein extract from the cell pellet remaining after buffer extraction. The 
SDS-PAGE gels are shown in figure 3.19. The washes from LiCl and KSCN extracts 
were also analyzed by 2-Delectrophoresis and pictures of the gels are shown in 
figures 3.20a, b, and c, respectively. Protein (5 µg) was applied to IPG strips (pH 3 – 
10) and focused by IEF. The proteins in the IPG strips were then separated according 
to molecular weight on Bis-tris gels (4 – 12 %). The 2-DE protein gels were silver 
stained. For comparison of the protein pattern in the buffer extracts with the whole 
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cell proteins the 2-DE gel of the total protein extract (3.6.2, fig. 3.17 b) are included 
in fig 3.20 d.  
 
Figure 3.19 SDS-PAGE gels from the tested buffer extracts. Each buffer extraction (a) is aligned with 
its remaining total protein extract (b) to the right, except for number 1 which is the wash extraction. 20 
µl (wash or buffer) or 5 µl (cytosol) of the protein extracts were loaded in each lane. The gels were 
Coomassie stained. The dashed lines delineate different gels. The letters A, B and C indicates the bands 
that were investigated at the proteomics course (section 2.7 and 3XX). The list of the buffers is given in 
table 3.8 
           
Figure 3.20a Picture of 2-DE gel of the wash Figure 3.20b Picture of 2-DE gel of the LiCl 
extract (20 mM Tris (pH 7.5) – 1 min).  (1.5 MLiCl in 20 mM Tris (pH 7.5) – 15 min).       
See table 3.8 and above text for details.  See table 3.8 and above text for details. 
    1         2a     2b       3a      3b       4a       4b      5a      5b      6a    6b      7a      7b      8a        8b 




Figure 3.20c Picture of 2-DE gel of the KSCN           Figur 3.20d Picture of 2-DE gel of the total 
extract (1 M KSCN in 20 mM Tris (pH 7.5)     protein in 20 mM Tris (pH 7.5) This picture is -
15 min). See table 3.8 and above text for                     identical to the picture given in fig 3.17 b. See                                        
details.      section 3.6.2 and above text for details. 
 
3.6.4 Shift experiments, 2-D electrophoresis and Protein Mass Fingerprinting 
3.6.4.1 Protein extraction and 2-D electrophoresis of bile and bile salts stimulated 
Bacillus cereus  
Bacillus cereus ATCC 14579 was grown and shifted to new media containing bile 
and bile salts to give final concentrations of 0.031 % (w/v) and 0.005 (w/v), 
respectively, as described in 2.2.7.  
 
A buffer extraction procedure, selected on the basis in results described in section 
3.6.3.2, using 1.5 M LiCl in 20 mM Tris (pH 7.5) containing protease inhibitor was 
used. The entire bacterial culture (200 ml) was harvested and proteins were isolated as 
described for the control culture (A) at 0 and 30 minutes after the shift and from bile 
(B) and bile salts (C) cultures 30 minutes after the shift. The experiment was done in 
three parallels and all extracts was analyzed by 2-D electrophoresis.  
 
The 2-D gels were silver stained and analyzed with the ImageMaster™ 2DE Platinum 
6.0. The 2-DE gels from B30 (bile) and C30 (bile salts) were compared to A0 
(control). Protein spots that had increase or decrease in volume % in either B30 or 
C30 were listed. Those protein spots showing similar pattern when comparing A30 to 
A0 were excluded to make sure the changes in volume % observed were due to the 




A summary of the results with regard to cell densities at time of harvest, protein yield 
and the number of spots identified in each parallel is shown in table 3.11. None of the 
samples showed any detectable aminopeptidase C activity. 
Table 3.11 A summary of the results for the buffer extraction of proteins after the shift. Cell density, 
protein yield and number of different spots on 2-DE gels from LiCl protein extracts after shift 
experiments. The entire culture (200 ml) in each parallel was used for extraction. The number 












A0 1 2.1x107(1) 34(2) 82 
A0 2 1.9 x107(1) 34(2) 77 
A0 3 2.8 x107(1) 36(2) 82 
A30 1 7.1 x107 34 65 
A30 2 9.1 x107 50 65 
A30 3 9.8 x107 47 63 
B30 1 2.9 x107(1) 36(2) 68 
B30 2 2.6 x107(1) 43(2) 66 
B30 3 3.6 x107(1) 39(2) 65 
C30 1 5.3 x107 22 72 
C30 2 6.0 x107 17 71 
C30 3 6.2 x107 20 67 
Because of low protein yield in A0 and B30 proteins form two extractions were combined for each 
parallel (1) Mean cell density of two experiments. (2) Sum protein yield of the experiments. 
 
The 2-DE gels were normalized, compared and spots were matched using the 
ImageMaster™ 2DE Platinum 6.0. Synthetic gels were made to facilitate comparison. 
20 spots were identified as being differentially regulated in the different samples. Two 
of these were identified by PMF (3.6.4.2) and are assigned by name; enolase and dhla 
(=dihydrolipoamide dehydrogenase). Spots, their average volume %, and the standard 
deviation between the three parallels in each sample are shown in Table 3.12. The 
log2 ratio between all cultures at 30 minutes and control at 0 minutes samples (log 2 
(A30/A0), log2 (B30/A0), and log2 (C30/A0) is also given.  
 
Eight spots in bile treated sample (B30) and seven spots in bile salts treated sample 
(C30) were identified to be up-regulated compared to both controls (A0 and A30). 




The 2-DE gels are shown in figures 3.21 to 3.24. A representative gel is shown for 
each sample (A0, A30, B30 and C30). These 2-DE gels without the spot markers can 
be found in appendix IV along with the other gels and synthetic gels. 
Table 3.12 List of spots on the gels showing increase/decrease in the volume %. The mean volume % 
and the standard deviation between three replicates is given for each spot in each gel. Each spot is 
compared to its matched spot in the control gel (A0) and the log2 ratio is given. Vol %s marked with 
bold indicates significant up-regulation and vol %s marked with italic indicates significant down-
regulation when compared to the control at both 0 and 30 minutes (A0 and A30). The spot numbers 
match those in the gels. The approximate MW and pI are also listed. NI indicates that the spot was not 
indentified in that gel, and thus the arrow (↓) means high degree of down-regulation. 
1 Aproximate MW and pI. Spots 2 and 6 were identified to be enolase and dihydrodhlaoamide 
dehydrogenase by protein mass fingerprinting, repectively. 
 
      
  
Control - 0 
min (A0) Control -30 min (A30) 
Bile treated - 30 min 
(B30) 
Bile salts treated- 30 
min (C30) 
Spot 
# MW1 pI1 Vol% St.dev Vol% St.dev 
Log2 
ratio  Vol% St.dev 
Log2 
ratio Vol% St.dev 
Log2 
ratio 
1 54 4.7 0.7 0.15 1.0 0.45 0.36 0.5 0.22 -0.45 1.9 0.77 1.31 
22 46 4.7 1.6 0.41 1.3 0.79 -0.29 2.8 0.43 0.77 0.5 0.03 -1.85 
3 22 4.9 2.0 0.46 1.8 1.03 -0.20 1.7 0.87 -0.30 4.4 1.18 1.10 
4 38 4.7 0.3 0.21 NI    1.2 0.58 1.84 1.1 0.40 1.72 
5 55 4.9 1.2 0.24 1.1 0.19 -0.13 1.4 0.53 0.20 3.0 0.69 1.31 
62 50 5.2 2.1 0.49 4.0 1.03 0.95 7.2 0.86 1.79 6.5 0.39 1.66 
7 66 4.9 7.9 1.13 5.2 0.43 -0.60 2.7 0.30 -1.56 3.7 0.68 -1.08 
8 22 8.8 0.2 0.06 NI    1.5 0.62 2.95 NI   
9 15 5.6 0.2 0.10 0.5 0.17 1.48 0.8 0.61 2.23 0.5 0.10 1.58 
10 29 5.1 2.2 0.62 4.5 0.55 1.06 0.6 0.15 -1.89 1.1 0.24 -0.92 
11 19 5.2 1.2 0.38 2.3 1.08 0.90 2.6 1.85 1.08 3.0 1.02 1.30 
12 61 4.7 1.2 0.22 NI    0.7 0.19 -0.74 0.2 0.24 -2.39 
13 51 4.8 0.2 0.11 NI    NI    0.6 0.13 1.72 
14 73 5.8 0.9 0.12 NI    NI    2.8 0.31 1.62 
15 18 4.8 1.4 0.63 1.8 0.22 0.33 0.7 0.22 -0.98 0.4 0.12 -1.71 
16 52 5.3 0.7 0.10 0.8 0.36 0.17 1.5 0.67 1.09 0.4 0.07 -0.67 
17 53 9.5 0.5 0.12 0.6 0.07 0.33 0.9 0.36 0.98 0.4 0.26 -0.43 
18 28 4.8 0.7 0.13 0.8 0.09 0.11 NI   ↓ 0.4 0.10 -0.99 
19 15 10 1.3 0.34 0.8 0.26 -0.71 6.0 3.39 2.18 0.7 0.37 -0.83 




Figure 3.21 Picure of 2-DE gel of LiCl extract of B. cereus harvested from the control culture after 0 
minutes (A0). 5 µg protein was separated by isoelectric focusing (pH 3 – 10) in the first dimension, and 
separated by MW in the second dimension. The gel was silver stained. Marked spots indicate spots that 


















Figure 3.22 Picture of 2-DE gel of LiCl extract of B. cereus harvested from the control culture after 30 
minutes (A30). 5 µg protein was separated by isoelectric focusing (pH 3 – 10) in the first dimension, 
and separated by MW in the second dimension. The gel was silver stained. Marked spots indicate spots 



















Figure 3.23 Picture of 2-DE gel of LiCl extract of B. cereus harvested from the bile (0.25 %) treated 
culture after 30 minutes (B30). 5 µg protein was separated by isoelectric focusing (pH 3 – 10) in the 
first dimension, and separated by MW in the second dimension. The gel was silver stained. Marked 
numbers indicate differentially expressed proteins in one or both of the bile/ bile salts cultures when 
compared to A0. Spot numbers 2, 4, 6, 8, 9, 16, 17, and 19 have an increased volume % after 30 
minutes bile treatment compared to both A0 and A30. Spot number 7, 10, 15, 18, and 20 shows a 
decrease in the spot volume compared to A0 and A30. (Spot 18 is not identified in this gel and is 


















Figure 3.24 Picture of 2-DE gel of LiCl extract of B. cereus harvested from the bile salts (0.005 %) 
treated culture after 30 minutes (C30). 5 µg protein was separated by isoelectric focusing (pH 3 – 10) in 
the first dimension, and separated by MW in the second dimension. The gel was silver stained. Marked 
numbers indicate differentially expressed proteins in one or both of the bile/ bile salts cultures when 
compared to A0. Spot numbers 1, 3, 4, 5, 6, 13, and 14 have an increased volume % after 30 minutes 
bile salts treatment compared to both A0 and A30. Spot number 2, 7, 8, 10, 15, 16, 18 and 20 shows a 
decrease in the spot volume compared to A0 and A30. (Spot 8 is not identified in this gel and is 




3.6.4.2 Protein Mass Fingerprinting 
Eight spots; 4 from B30, and 4 from C30 where excised, trypsin digested and 
analyzed by MALDI-TOF MS. The mass spectra were recorded for masses ranging 
from 1 kDa to 4 kDa. The lower parts of the spectra (700 Da to 1kDa) were excluded 
due to high background noise. The masses obtained in the spectra were exported to 
the Mascot program and the protein was identified. This was repeated for the same 
spots in parallel gels. Unfortunately, probably due to low peptide concentration and/or 















identified. The identified protein spots were; spot 2: Enolase (BC5135) and spot 6: 
Dihydrolipoamide dehydrogenase (BC3970). The mass spectra are shown below in 
figures 3.25 a and b, and 3.26 and the results from the Mascot identification is given 
in table 3.13. 
 
 
Figure 3.25a MALDI-TOF mass spectrum of spot 2 on gel B30 – 1. The peaks in the spectrum were 
identified as belonging to tryptic peptides of the Bacillus cereus ATCC 14579 protein enolase 
(BC5135). 
 
Figure 3.25b MALDI-TOF mass spectrum of spot 2 on gel B30 – 2. The peaks in the spectrum were 
identified as belonging to tryptic peptides of the Bacillus cereus ATCC 14579 protein enolase 
(BC5135). 
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Figure 3.26 MALDI-TOF mass spectrum of spot 2 on gel C30 – 2. The peaks in the spectrum were 
identified as belonging to tryptic peptides of the Bacillus cereus ATCC 14579 protein 
Dihydrolipoamide dehydrogenase (BC3970). 
 
Table 3.13 Spots identified by PMF. All spots had a MOWSE score above the threshold-value; 77 
(defined by the Mascot program). No other proteins gave scores above the threshold-value. The spot 
localizations on the gels match the theoretical MW and pI.  
Spot 




matched(2) MW(1) pI(1) 
Exicesed 
from gel # 
2 Enolase(3) BC5135 80(3) 16 46.4 4.66 B30 - 1 
2 Enolase BC5135 84 18 46.4 4.66 B30 - 2 
6 
Dihydrolipoamide 
dehydrogenase BC3970 92 13 49.7 5.25 C30 - 2 
(1)Theroretical MW and pI. (2)Mass values matched to theoretical peptides. Some of the masses matched 
the same peptide. (3)The score for this spot was obtained by increasing the peptide tolerance to 2.5 Da 
 
3.6.5 Practical proteomics in York 
A CTAB extraction (section 2.6.1.3) was analyzed by 2-DE on 18 cm IPG strips. A 
picture of the gel is given in fig 3.27. The three gel bands (A, B, and C) indicated in 
figure 3.19 was analyzed by both MALDI-TOF MS and MALDI TOF-TOF MS/MS. 
The peptides from the five highest peaks in the MALDI TOF spectra were 
fractionated and analyzed by TOF/TOF. Below in table 3.14 is the mascot results for 
the MALDI-TOF MS. The peptide fractionated by MS/MS all matched to the 




























1505.1 1652.6 2026.01142.1 1494.1 2187.5 2297.7
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corresponding peptide. All these spectra cannot be included due to space limitations, 
but an example from one of the peptides of the flagellin gene is shown in figure 3.28. 




Figure 2.27 2-D gel of CTAB extract done at the practical proteomics course. ~60 µg protein was 








Table 14 Proteins identified from digested 1-D gel band at the practical proteomics course. The excied 
gel bands can be seen in figure 3.19. The parameters used in the Mascot program is the same as 
specified previously (2.6.5.3) except for the peptide tolerance, which was set to 0.2 for these searches. 
Band 
# 







A Anitgen BC3699 120 18 36.2 7.71 
B Fructose-bisphosphate aldolase BC5335 126 23 30.8 5.00 
C Flagellin BC1658 119 29 29.4 5.21 
1Theroretical MW and pI. 2Mass values matched to theoretical peptides. Some of the masses matched 





Figure 3.28 Section of MS/MS spectra of a 1419 Da peptide of flagellin (BC1658). The peptide 
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4 DISCUSSION AND CONCLUSIONS  
 
4.1 Introduction  
4.1.1 From genotype to phenotype 
The complete genome sequence defines the total number and types of genes that a 
bacterium contains, and this may tell something about this bacteria’s way of life. 
However, too little information exists about genes function and types of regulation to 
get a reliable overview of the full metabolic and physiological potential of a 
bacterium. The genes are subjected to regulation, which are reflected as the mRNA 
copy number, and quantification of mRNA levels can provide information about 
which genes are active and necessary for living in a given set of condition or 
microenvironment. The mRNA, is also subject to regulation (turn-over rate, RNAi, 
initiation of transcription etc) and does not adequately define those proteins that are 
expressed at specific times or under specific condition. After all, it is in general the 
proteins that are the functional units and consequently responsible for physiological 
changes.  
 
In this thesis responses to conditions mimicking the human GI-tract were investigated 
in B. cereus. It was interesting to see if such conditions could induce changes, at the 
mRNA and protein levels, which could be correlated to virulence responses. Initially 
physiological responses to bile and bile salts were investigated. Then we looked for 
homologue genes in B. cereus ATCC 14579 that were known to be involved in 
survival and colonization of the GI-tract in other bacteria. Expression of these 
homologue genes was investigated in real-time RT-PCR and microarray experiments. 
The expression changes were also investigated at the protein level by 2D protein gel-
electrophoresis. 
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4.1.2 Remarks 
After working for one year with B. cereus I am left with a wealth of data and results. 
Some of the data and most of the results are presented in the results section because 
they document the entire process. However, a lot the data is of less interest when the 
over-all aims are taken into consideration. Consequently I have therefore chosen, in 
this discussion, to focus on the biological responses observed. Technical detail about 
methods etc. will only be discussed if they are of central relevance.  
 
It should also be noted that the microarray chips only become available to us this 
autumn and were not originally a part of this thesis. What is presented here is only the 
start of the microarray project. Although I did the analysis and participated in the 
experimental design and shift experiments, the RNA isolation and hybridization were 
performed by Ine Robertsen and Solveig Ravnum. However, the results are highly 
relevant to my work, and I think it would be wrong to not include them. With this in 
mind I have therefore focused on the other subjects in this work, even though they do 
not generate the volume of data generated by microarray analysis.  
 
4.2 Simulating in vivo conditions in vitro 
No mammalian model organism is available for studies of B. cereus infections. 
Therefore, we have in this thesis developed a system that could mimic some of the 
conditions found in the intestinal environment. Complete simulation of the intestinal 
environment in vitro is of course impossible. In the mammalian GI-tract a numerous 
number of different conditions are found which are radically different from the usual 
conditions that B. cereus is subjected to in natural habitats such as soil and foods. 
Amongst the new challenges bacteria encounter when entering the GI-tract are: an 
acidic environment, variation in pH, elevated osmolarity, oxygen starvation, nutrient 
competition (Chowdhury et al., 1996), immune response and exposure to a number of 
different potentially toxic compounds (degradative enzymes, detergents etc.) In this 
work the some of the conditions found in the mammalian GI-tract are simulated using 
bile (and bile salts) and mucin in the culture media. Bile is a specific component of 
the GI-tract and mucin is present on the surfaces of all cavities in the body, including 
the GI-tract (see introduction). Bile is restricted to the small intestine, while mucin is 
present throughout the GI-tract in various types and abundance. Bile and mucin also 
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are effective barriers against pathogenesis (see introduction) and it is likely that 
responses are induced in enteric bacteria when they are encountered. It has been 
demonstrated that a number of bacteria (Salmonella, Shigella, Enterococcus  and 
Campylobacter among others) use bile as a localization signal for the GI-tract and 
alter expression of virulence genes (Pegues et al., 1995; Pope et al., 1995; Rivera-
Amill et al., 2001; Van Velkinburgh & Gunn, 1999; Waar et al., 2002).  
 
In this work we have developed a system that simulates some of the conditions found 
in the GI-tract by adding bacteria suspensions to culture media containing different 
concentrations of bile, bile salts and mucin (section 2.2.7 and 3.1.4). Due to the toxic 
effect of bile (and bile salts) the bacteria suspension was added to an equal volume 
culture media with non-lethal concentration of bile/bile salts. This ensures that no 
bacteria are exposed to locally lethal concentration as they might if the bile (or bile 
salts) were added directly to the bacteria culture. The shifts are performed in 
exponential growth to avoid biased results, attributed to stress, which would arise 
when the bacteria enter the stationary phase 
 
The mucin was dissolved and sterilized in NaOH, and pH adjusted with HCl, and then 
added to NaCl-free IR-media (section 2.2.1). Sterilization was achieved but the mucin 
did denature over time. There were also some problems in the isolation of RNA from 
the mucin cultures. In the real-time experiments none of the investigated genes (also 
those investigated by Sirnes (2005)) showed any expression changes. One explanation 
could be that the bacteria used the mucin solely as a carbon source which is observed 
in other experiments using mucin in vitro (Chang et al., 2004). For these reasons the 
shift to mucin containing medium experiment was only investigated using real-time 
PCR. 
 
4.3 Cellular effects of shift experiments 
No cellular response to a shift to mucin containing medium were observed, 
consequently it will not be discussed here. 
 
A number of studies report that gram positive and gram negative enteric pathogens 
have an elevated or increased tolerance to bile (Begley et al., 2002; Brook, 1989; 
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Flores et al., 2003; Prouty & Gunn, 2000; Van Velkinburgh & Gunn, 1999). Pre-
exposure to sub-lethal concentrations can also increase the tolerance. 
 
B. cereus ATCC 14579 cannot survive physiological bile and bile salts 
concentrations, and the tolerance is not increased by pre-exposure to bile salts (see 
sections 3.1.2 and 3.1.3). Bile salts (LB-agar plates with 0.02 %) completely inhibited 
growth with an observed MIC between 0.01 and 0.02 % (table 3.2). Bile salts 
concentration in the intestine range from 0.2 to 2 % (Dawson, 1998).  Exposure to 
0.375 % bile led to a rapid killing of bacteria, and 0.0375 % led to a reduced growth 
rate (see figure 3.2 and 3.3). Therefore it seems that B. cereus ATCC 14579 
vegetative cells cannot survive in the human GI-tract. There may be other reasons to 
these observations. Firstly, the in vitro simulation does not exactly represent the 
intestinal environment and there could be other parameters that will effect survival. 
The bile used in these experiments is purified bovine bile which is of another 
composition to that of human bile (although the human bile is supposedly more toxic 
to bacteria). The bile acids (salts) used are unconjugated cholic acid and deoxycholic 
acid, and consequently more hydrophobic and toxic than the secreted conjugated bile 
acids. It is possible that B. cereus ATCC 14579 is more tolerant to the bile salt 
composition encountered in vivo. In a review by Begley et al. (2005) about bile and 
bacteria, it is suggested that this explanation for the low bile salts tolerance observed 
in vitro in Enterococcus faecalis, a human pathogen. However, Spinosa et al. (2000) 
reported a slightly higher tolerance for tauroconjugated deoxycholic acid (TDOC) 
which had a MIC of 98 µg/ml (~0.01 %) while deoxycholic acid (DOC) had a MIC at 
78 µg/ml in B. cereus AF172711. It should, in this case, also be noted that longer 
adaptation periods could increase tolerance, something which was observed in 
experiments with  Propionibacterium (Leverrier et al., 2003); maximum adaptation 
was observed after 4 hours pre-treatment and no adaptation was observed after 5 
minutes. 
 
Secondly, the bacteria could be protected by the food matrix and/or the bile could be 
“occupied” in binding food constituents. Similar results are seen for survival of 
Bacillus cereus in acidic environments. Clavel et al. (2004) incubated Bacillus cereus 
in culture media containing 50 % (w/v) of different foods and monitored survival after 
exposure to different pHs. Although vegetative cells were rather sensitive towards 
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acid, B. cereus tolerated pH 3.6 when incubated with milk, which was 0.5 to 1 pH-
point lower than that observed with other foods. The bile salts concentrations are also 
subjected to high variations (from 0.2 to 2 %) in the intestine. However, these 
concentrations can differ according to ingested foods and from person to person 
(Dawson, 1998). Since bile salts are reabsorbed by passive diffusion in the length of 
the small intestine, and by active transport in the distal ileum, the concentration of bile 
would decrease in the intestine. Though the results indicate that it is unlikely that 
vegetative cells of B. cereus ATCC 14579 can survive intestine via the oral route, it is 
possible that they could proliferate in the large intestine. 
 
The reason for the low bile (and bile salts) tolerance observed in B cereus could be 
one or more of the above reported observations. However, to my knowledge, other 
commensial and pathogenic intestinal bacteria investigated, have a tolerance to bile 
and/or bile salts concentrations that are at least a factor of 10 higher than the tolerance 
observed in B. cereus ATCC 14579 (Begley et al., 2002; Flahaut et al., 1996; Prouty 
et al., 2004; Spinosa et al., 2000; Taranto et al., 2003; Waar et al., 2002). 
 
Therefore, from my point of view, the only opportunity for B. cereus ATCC 14579 to 
survive in the intestine would be as spores, and they could germinate when and where 
the conditions allow it (e.g. in the mucus layer in the distal ileum or in the large 
intestine). In experiments on rats B. cereus F4433/73 spores have been isolated from 
all parts of the intestine while vegetative cells showed little or no survival (Wilcks et 
al., 2005). B. cereus spores also survive acidic environments (pH 1.3) while 
vegetative cells at best survive pH 3.6 (which is significantly higher than the pH in the 
stomach) (Clavel et al., 2004). Andersson et al. (1998) have showed that B. cereus 
spores can adhere to endothelial cells and they suggested that this could be one of B. 
cereus virulence mechanisms. To my knowledge the bile tolerance of B. cereus spores 
is not investigated. However, the bile salts concentration in the distal ileum and the 
large intestine is approximately 5 % of what is observed in the upper part of the small 
intestine. This would correspond to a minimum ~0.01 % bile salts (Dawson, 1998). 
This bile salts concentration (0.01 %) is in the range of B. cereus ATCC 14579s 
observed MIC, and most likely in this part of the GI-tract they can germinate. 
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Although the data strongly suggests that B. cereus ATCC 14579 is unable to survive 
the environment in the GI-tract this does not necessary mean that other B. cereus 
strains also lack the ability to survive, as bile tolerance is thought to be a strain 
specific (see introduction).  
 
It is possible that diarrhea caused by B. cereus is not dependent on colonization of the 
GI-tract. The plcR-regulon (the principle regulator of enterotoxins and degradative 
enzymes in B. cereus, see introduction) is regulated, at least in vitro, in a quorum 
sensing manner, with an expression maximum at ~109 cells. This suggests that B. 
cereus would have to increase in number after ingestion, and not decrease as seems to 
be the case with B. cereus ATCC 14579. 
 
4.4 Methods for detection of expression 
In this section I will briefly discuss the advantages and disadvantages of the methods 
used for the quantification of RNA, the protein levels and the isolation of proteins. 
 
4.4.1 Real-time RT PCR, microarray and 2D protein gel-electrophoresis 
Real-time PCR and microarray 
The major differences in real-time RT PCR and microarray in the quantification of 
mRNA is sensitivity. In real-time RT PCR genes expressed at very low levels can be 
detected (in theory one RNA molecule is sufficient); while in microarray more copies 
of RNA must be present in order to obtain reliable signals from Cy3/Cy5. At the other 
end of the scale, real-time RT PCR is also more reliable, and there is no upper limit 
for the level of detection (if necessary samples can be diluted). In microarray 
experiments the spots becomes saturated when the cDNA is very abundant, something 
which leads to bias in the observed ratios. However, for genes that are moderately 
expressed and regulated there is a good correlation between microarray and real-time 
RT PCR experiments. There is one exception: the ratios between differently regulated 
genes seem to be about 2 -10 fold higher in real-time RT-PCR than ratios in 
corresponding microarray (Reviewed by Conway & Schoolnik, 2003). Therefore one 
should include in the results the genes that display only small changes in regulation in 
microarray data, as these would probably be more visible when documented by real-
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time RT-PCR. In this work all genes that had an up/down-regulation of 1.5 (log2 
0.59) are included (section 2.5.3 and 3.5.2). 
 
2-D protein gel-electrophoresis 
In this thesis 2-DE and silver-staining of the gels has been used to detect shift in 
protein expressions (section 2.6.4 and 3.6.4). Silver staining, SYPRO Ruby staining 
and Cy3/Cy5 labeling (used in DiGE) are all sensitive markers, but none of them is as 
sensitive as radio-labeling. Though a widely used method there are some problem 
with silver staining: Proteins expressed at a low level are hardly detected, silver-
staining lack an end-point in the development and  the spots become saturated.. While 
the strongest spots may be saturated, prolonged developing would bias the ratio since 
weak spots will increase in intensity proportional with the time of development. It is 
also difficult to stop the developing reaction at exactly the same global intensity for 
different gels. The dynamic range of silver-staining has a 7 - 40-fold range of 
linearity, which is significantly lower than the differences in protein expression in 
vivo which ranges from a few copies to several ten-thousands copies in a single cell. 
This would bias the ratio of weak and strong spots. The use of volume or relative 
volume (vol %) for quantification removes part of this problem, since strong spots 
would occupy a larger area on the gel than weak ones. Gels with different global 
intensities can be normalized using software analysis programs, but overall there 
could be substantial bias in the spot ratios. Care must be taken when using computer 
programs to analyze expression pattern, and with silver-stained gels they should only 
be used as indication. All spot should also be confirmed by visual examination.  
 
Although both 2-DE with silver stain and microarray are at best are semi-quantitative 
methods, the direction of expression can be inferred. The exact fold-changes of 
expression, are however, of minor importance, and it is rather the documentation of a 
response that is of interest as this implies a biological response. 
4.4.2 Protein extraction 
Some surface proteins may be crucial for colonization of GI-tract and virulence. 
Therefore a number of buffers that hopefully would extract these proteins, with 
minimal cytosolic contamination were tested. A number of reports concerning buffer 
extraction of surface proteins, are to be found in the literature (Antelmann et al., 
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2002; Nilsson et al., 2000; Schaumburg et al., 2004; Tavares & Sellstedt, 2000; 
Wright et al., 2005). 
 
Most of the buffer extracts tested did not show any cytoplasmic protein 
contamination, as measured by the presence aminopeptidase C activity (see section 
3.6.3.1). The NP-40 protein extract had substantial aminopeptidase activity, and it is 
can be concluded that the presence of this detergent in the buffer lead to cell 
disruption.  
 
The assay was also tested with protein extracts which had been concentrated, but this 
led to variable results (data not shown). For these reasons the assay as it was 
described by Schaumburg et al. (2004) was used, although it fails to detect low 
aminopeptidase C activity in samples containing low protein concentrations (see 
below).  
  
Analysis of the different protein extracts using  SDS polyacrylamide gel protein gel 
electrophoresis (see section 3.6.2.2, figure 3.19) shows there was little difference 
between the different buffers (except NP-40) and the very low aminopeptidase C 
activity indicates that these buffers did not disrupt the cells as observed in the NP-40 
extraction. On the other hand the buffer extracts exhibit strong similarities to the 
cytosolic fractions. (This is not so obvious on the pictures, but was clear in the 
original gels. This was also observed for the wash extract.) The 2-DE gel (when equal 
amounts of protein were loaded, see figure 3.20a-d) of the whole cell extraction did 
reveal a pattern of spots highly similar to the extracts, and it seems that the buffer 
extracts contains whole cell proteins from a low number of cells, but with a higher 
proportion of surface proteins in the buffer extracts. (The total protein 2D –gel is 
somewhat underfocused, but it reveals a similar pattern.) No aminopeptidase C 
activity was detected in the extract. This is in contrast to the pattern on the 2-DE 
protein gels, where one can clearly see the similarity between whole cell extract and 
buffer extract which is a strong indication of the presence of cytosolic proteins. Even 
though it is probably that is a higher portion of surface proteins in the buffer extracts, 
they are certainly not exclusively surface proteins and are therefore described as 
buffer extracts rather than the cell surface proteins. 
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Since the cells are washed, cytosolic proteins must result from lysis during the buffer 
treatment. The rigidity of gram positive cells suggests that this is a controlled 
behavior, and not a result of the relatively mild buffers. It has very recently been 
reported that when exponentially growing bacteria of the B. cereus group was 
transferred from growth media to buffered solution rather extensive autolysis is 
observed (Raddadi et al., 2005). This phenomenon is probably the explanation for the 
presence of cytosolic proteins in buffer extracts.  
 
Two other methods are described for the isolation of surface proteins. One method is 
to label proteins on intact cells with biotin-linked markers or fluorescent dyes such as 
Cy3/Cy5 and then harvest or detect the labeled proteins (Sabarth et al., 2002). The 
other method is based on isolation of the cell wall by centrifugation, and then degrade 
the cell wall enzymatically or chemically and harvest the proteins (Mauri et al., 1999). 
Seeing the results discussed above and if given more time, one of these methods 
would be preferable if one wished to specifically investigate cell surface proteins. 
 
4.5 Function of identified and regulated genes  
As previously mentioned, intestinal bacteria must survive the lethal effect of bile and 
to maintain their presence in the intestine they must adhere to the host endothelial 
cells. B. cereus ATCC 14579 genes that could assist in colonization of the GI-tract 
were investigated in a bioinformatics based analysis. The results shown in table 3.2 
indicate that B. cereus ATCC 14579 has some genes that could be used in 
colonization of endothelial cells the GI-tract. Some of these genes were investigated 
by real-time PCR and are discussed below. Collagen adhesion proteins, cell-wall 
binding protein (enterotoxin) and camelysin were not further investigated and are thus 
not discussed. Sirnes (2005) investigated 52 genes involved in bile response in L. 
monocytogenes, S. typhimurium, Lactobacillus plantarum and Enterococcus faecalis 
with regard to similarity to genes in the B. cereus ATCC 14579 genome. None of the 
investigated genes had any significant similarity.  
 
In addition, will the functions of the proteins identified by 2-DE and PMF be 
discussed here (see section 3.6.4.1 and 3.6.4.2). 
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Fibronectin binding protein 
Fibronectin is a dimeric glycoprotein present in plasma, extracellular fluids and at cell 
surfaces in fibrillar (Reviewed by Romberger, 1997). The fibronectin binding protein 
(FBP) of Bacillus cereus ATCC 14579 is highly similar to those of Streptococcus spp. 
and Listeria monocytogenes (section 3.2.1), and the binding properties of FBP in 
these organisms are well documented (Gilot et al., 1999; Gilot et al., 2000; Joh et al., 
1999; Joh et al., 1994). Streptococcus pyogenes, Streptococcus gordonii, 
Staphylococcus aureus, and Listeria monocytogenes all uses fibronectin binding 
protein as a virulence factor that is involved in invasion and/or adhesion of host cells 
(Christie et al., 2002; Dramsi et al., 2004; Joh et al., 1999).  
 
Internalin 
Internalins are well documented proteins in Listeria monocytogenes, where they 
mediate invasion of host cells (Reviewed by Cossart et al., 2003). The internalin A 
proteins mediate invasion by binding to E-cadherin and consists of leucine rich 
repeats which are thought to be responsible for the binding process (Cossart et al., 
2003). The internalin A proteins of Bacillus cereus only are ~25 % similar to those in 
L. monocytogenes so any conclusion about parallel functions seem unreasonable 
(section 3.2.1). However, they do have surface binding signals and leucine rich 
repeats (which exists in many proteins and are responsible for protein-protein 
interactions (Kobe & Kajava, 2001)). They may therefore be implicated in virulence 
in B. cereus ATCC 14579. In L. monocytogenes the internalin-machinery and fbp are 
associated and essential for full virulence (Dramsi et al., 2004).  
 
Enolase 
Enolase (phosphopyruvate hydratase, section 3.2.1.) is an enzyme (EC 4.2.1.11) in 
glycolysis which catalyses the formation of phosphoenolpyruvat from 2-
phosphoglycerate or vice versa; 2-phospho-D-glycerate ↔ phosphoenolpyruvate + 
H2O. It can also catalyse the reaction 3-dehydroquinate ↔ 3-dehydroshikimate + H2O 
in aromatic amino acid biosynthesis. However, this protein has also been documented 
as having several other (moonlighting) functions according to the organism and sub-
cellular localization. It forms a structural component of lens in vertebrates (Williams 
et al., 1985; Wistow et al., 1988). It has been documented as having DNA-binding 
properties in yeast (Algiery & Brewer, 1992) and its is described as an endothelial 
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hypoxic stress protein in bovine endothelial cells (Aaronson et al., 1995). It is also 
present at surfaces of some cancer cells, where it activates plasminogen and thus 
degrade the extracellular matrix in order to migrate (Lopez-Alemany et al., 2003). 
Most interestingly, in several bacteria this protein is expressed on cell surfaces where 
it can bind plasminogen. This ability is so far described for Group A Streptococci 
(GAS) (Pancholi & Fischetti, 1998), Streptococcus pneumoniae (Bergmann et al., 
2001), Bacteroides fragilis (Sijbrandi et al., 2005) and Listeria monocytogenes 
(Schaumburg et al., 2004). Plasminogen is the proenzyme of the protease plasmin, 
which is a protease that cleaves fibrin (fibrin is a extracellular matrix protein and also 
present in the mucosal barrier). It has also a high proteolytic activity against basal 
lamina proteins, such as thrombospondin, laminin, fibronectin and fibrinogen 
(Reviewed by Cesarman-Maus & Hajjar, 2005). Pancholi et al. (2003) suggested that 
GAS may exploit enolases plasminogen-binding property for dual purposes i.e. 
initially to adhere pharyngeal cells and then for tissue invasion by the use of 
plamsin(ogens) proteolytic activity. The identification of antibodies against 
streptococcal enolase in patients infected with S. pneumoniae (Fontan et al., 2000) 
also supports the idea that enolase is present on surfaces, and an important virulence 
factor. Interestingly, it has recently been documented that the enolase of 
Streptococcus sobrinus has immunosuppressive activity (Veiga-Malta et al., 2004). 
However, it is not possible to tell if this protein is present on the surface of B. cereus 
and if it has the ability to bind plaminogen without further investigations, and its role 
in bile response remains uncertain. 
 
Dihydrolipoamide dehydrogenase 
Dihydrolipoamide dehydrogenase (EC 1.8.1.4) is the flavoprotein component of the 
multienzyme 2-oxo-acid dehydrogenase complexes such as pyruvate dehydrogenase 
and 2-Oxogluterate dehydrogenase. It binds to the core enzyme and catalyses 
oxidation of its dihydrolipoyl groups: protein N6-(dihydrolipoyl)lysine + NAD+ ↔ 
protein N6-(lipoyl)lysine + NADH + H+. B. cereus ATCC 14579 contains  three 
paraloges of this protein; BC2776, BC3970, and BC4160. There have been some 
reports of dihydrolipoamide dehydrogenase-domain-proteins, and other pyruvate dhg 
components of microbes surfaces (Bringas & Fernandez, 1995; Dallo et al., 2002; Li 
de la Sierra et al., 1997; Moreno-Brito et al., 2005). 
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4.5.2 Changes in gene-expression and their involvement in bile response 
A number of studies describe bile responses for both commensial and 
enteropathogenic bacteria. In general the responses are stress responses similar to 
those induced by heat, acid, osmolaritly, and specific responses to bile (see 
introduction). As mentioned above Sirnes (2005) investigated the genome of B. 
cereus ATCC 14579 and found no genes involved in specific bile response. However 
the microarray-data, real-time data and proteomic data suggest that a general stress 




The microarray data indicates a general stress response to bile /bile salts exposure in 
B. cereus ATCC 14579 (see table 3.7 and appendix IV). Typical stress genes such as 
the 10 and 60 kDa Chaperonins (GroESL), hrcA, DnaK, Hsp20, and ClpP which are 
involved in releaving stress caused by misfolded proteins are significantly up-
regulated, both compared to A0 and A30. This is similar to what is seen in other bile 
challenged bacteria (Flahaut et al., 1996; Leverrier et al., 2003; Schmidt & Zink, 
2000) In B. cereus many of these genes are under the control of the alternative 
transcription regulator SigmaB (Periago et al., 2002). Sirnes (2005) documented by 
real-time RT-PCR that sigmaB is highly up-regulated (~100 fold compared to A0) in 
cultures exposed to bile and slightly up-regulated (~7 fold compared to A0) in bile 
salts cultures. The up-regulation of superoxide dismutase and thioredoxine, both 
involved in protection against oxidative stress, may also be considered general stress 
responses. Superoxide dismutase is up-regulated by bile-challenge in P. 
freudenreichii (Leverrier et al., 2003) Thioredoxin is also up-regulated in bile 
stimulated cancer cells (Lechner et al., 2002). And a transcriptional regulator, Fur 
(ferric uptake repressor), is also up-regulated. B. cereus fur deletion mutants are 
avirulent against insect targets, and this gene is probably crucial for tolerance towards 
oxidative stress (Harvie & Ellar, 2005; Harvie et al., 2005).  
 
(Multi)drug-transporters are important in bile response (see introduction) and 3 drug 
resistance transporters (2 in bile media and 1 in bile salts media) are highly up-
regulated, something which could imply that they can have a function in removing 
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bile salt from the cells. However, next to nothing is known about the specificity of 
these (Multi)drug-transporters in B. cereus, and speculation in their involvement must 
be substantiated by experimental evidence. 
 
There is a down-regulation of many ribosomal proteins and proteins involved in 
oxidative phosphorylation, and up-regulation of genes involved in carbohydrates, 
amino acid and peptide metabolism (see microarray results in appendix IV). This may 
indicate a trend of directing energy metabolism towards fermentation and/or 
production of other metabolites. This also correlates well with results from bile 
stressed Bifidobacterium longum Sanchez et al. (2005) where an increase in glucose 
consumption was observed. 
 
It should also be noted that one generally accepted pathogenicity factor in B. cereus, 
Hemolysin BL lytic component L2,  is strongly down-regulated in bile media (log2:         
-2.31). 
 
Real-time PCR experiments 
The real-time PCR analysis shows that internalin genes are strongly down regulated 
in bile salts media; BC1331 (intB) is ~25-fold down-regulated and BC0552 (intA) 
also show the same pattern (see section 3.4.3, figures 3.12 and 3.13). They are also 
down-regulated in bile media, but not to the same extent. BC1331 is also confirmed 
down-regulated in bile salts microarray results (although the P-value is rather high, 
0.097). The down-regulation of internalin in a bile/bile salts response could be general 
a stress response, non-essential genes would be down-regulated, so energy can be 
utilized elsewhere. In L. monocytogenes the sigmaB is linked to regulation of 
internalin and bile response genes (Kazmierczak et al., 2003), internalin is not 
positively regulated by sigmaB in B. cereus ATCC 14579.  
 
The fibronectin binding protein gene does not appear to be significantly regulated.  
 
2-D protein gel-electrophoresis 
The enolase protein was up-regulated in bile and down-regulated in bile salts (see 
section 3.6.4; tables 3.12 and 3.13, and figures 3.21 – 3.24). Enolase is, to my 
knowledge, not identified in any studies describing responses to bile. However 
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Sanchez et al. (2005) observed up-regulation of glycolytic enzymes in bile stressed 
Bifidobacterium longum. This is also seen in the microarray data, suggesting that this 
metabolic shift is a common response to bile (or general stress). Enolase has been 
shown to be up-regulated in response to iron-depletion in a study aiming to identify 
virulence genes when Bacteroides fragilis encounters in vivo conditions, which 
implies that enolase is important in coping with different kind of stresses. Although 
enolase is a virulence factor in other species, such as Streptococcus this has not been 
investigated in B. cereus, and since the extraction of specifically surface protein was 
not unequivocal it would be unwise to draw any definitive conclusions as to the 
cellular localization of the enolase detected in the protein electrophoresis and 
identified by MS. On the other hand, the global change in metabolic genes and the 
down-regulation of other virulence factors suggests that the enolase of B. cereus is up-
regulated as part of the metabolic response in sugar metabolism.  
 
The up-regulation of enolase in the presence of bile, but not in bile salts could be 
ascribed to the lower growth-rate in media containing bile, which may suggest an 
increased need for energy. This might also be explained by the presence of something 
in the bile that the bacteria sense, but which is not present in the bile salts. Pope et al. 
(1995) discovered that a mix of the bile salts deoxycholate and chenodeoxycholate 
increased Shigellas invasiveness, while other structurally similar bile acids did not.  
 
Dihydrolipoamide dehydrogenase was up-regulated in both bile and bile salts samples 
(section 3.6.4; tables 3.12 and 3.13, and figures 3.21 – 3.24). The microarray-analysis 
confirms up-regulation of dihydrolipoamide dehydrogenase in bile salt media (but has 
a high P-value, 0.094). In the bile media this gene has a log2 ratio of 0.28, which is 
only a slight up-regulation (and might imply a regulation at the mRNA-level, or a bias 
of the results). BC4160, a paralogue dihydrolipoamide dehydrogenase gene is also 
strongly up-regulated in bile salts media. The role of dihydrolipoamide 
dehydrogenase in bile response (or stress response) is, to my knowledge, not 
investigated. The increased expression of dihydrolipoamide dehydrogenase probably 
indicates a need for more energy and/or more biosynthetic capacity and/or other 
metabolites.  
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It should also be noted that the response seen to bile and bile salts in the real-time 
experiments, especially with regard to sigmaB (Sirnes 2005), was only observed 30 
min. after the shift, which could indicate that the response is not induced by bile (-
salts) itself, but by more unspecific stimuli such as an accumulation of unfolded 
proteins and/or oxidative stress. This also implies that B. cereus ATCC 14579 do not 
sense bile (e.g. by two component systems) in a direct manner like other enteric 
bacteria probably do. 
 
Concluding remarks 
B. cereus ATCC 14579 does not tolerate bile and bile salt concentrations encountered 
in vivo. Bile (-salts) stimuli at non-lethal concentrations gives a stress response and 
shifts its metabolic priorities (real-time, microarray and 2-DE). Virulence (and 
putative virulence) factors like enterotoxin, internalin and fibronectin binding proteins 
are not affected or reduced by bile (-salts) (real-time and microarray). All in all this 
work implies that the vegetative cells of B. cereus ATCC 14579 do not show a 
response which is shown by true enteropathogenic bacteria.  
 
4.6 Further perspectives  
This work should be properly concluded; the microarrays should be presented in three 
replicas and some of the gene expression patterns should be confirmed by real-time 
reverse transcriptase PCR. The protein electrophoresis should either be, extended to 
total protein or focused on surface proteins using a more appropriate method for 
labelling, extraction and detection. 
 
Only one strain of B. cereus was investigated. Another B. cereus strain, preferable a 
clinical isolate, e. g. the recently sequenced B. cereus NVH391-98 would be a good 
candidate to investigate responses to bile/bile salt.  
 
Surface proteins that are putatively involved in binding to host cells could be done. 
Firstly such genes should be documented to be localized at the surface e.g. by in situ 
immunolabeling and their ability to bind host cells proteins should be determined. 
Then of course, if such proteins are positively identified, their involvement in 
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Appendix I: Protocol for RNA isolation using the FastRNA® Pro Blue Kit 
 
Section from the detailed protocol from the FastRNA® Pro Blue Kit 
 
1. Dilute 1 ml of an overnight bacterial culture into 14 ml of fresh media in a sterile 
50 ml tube or 250 ml flask. 
 
2. Incubate for ~4–6 hours at 37ºC with shaking at ~150–200 rpm to reach an OD600 
= 0.9–1.0 (Note: 1.0 OD600 for Escherichia coli is ~1 X 109 cells per milliliter). 
 
3. Remove 10 ml of the culture to a 15 ml conical tube and pellet the cells by 
centrifugation at 2,800 rpm (x 1,500 g) for 15 minutes at 4ºC (e.g., Beckman Model 
TJ-6 Centrifuge, I-92 Swinging Bucket Rotor) for 10 minutes. 
 
4. Decant the supernatant and add 1 ml of RNApro™ Solution to the tube. 
Completely resuspend the cells by pipetting or vortexing. 
 
5. Transfer 1 ml of the resuspended cells to a blue-cap tube containing Lysing Matrix 
B provided in the kit. Securely close the cap to prevent leakage in the next step. 
NOTE: The calculated volumes will provide adequate airspace in the matrix tube to 
prevent sample leakage and/or tube failure. DO NOT overfill the matrix tube. To 
process a greater number of cells use a second matrix tube. 
 
6. Process the sample tube in the FastPrep® Instrument for 40 seconds at a setting of 
6.0. 
 
7. Remove the sample tube and centrifuge at a minimum of 12,000 x g for 5 minutes 
at 4ºC or room temperature. 
 
8. Transfer the liquid (~750 μl) to a new microcentrifuge tube. Avoid transferring the 
debris pellet and lysing matrix. 
 
9. Incubate the transferred sample 5 minutes at room temperature to increase RNA 
yield. 
 
10. Add 300 μl of chloroform (NO isoamyl alcohol). Vortex 10 seconds. 
 
11. Incubate 5 minutes at room temperature to permit nucleoprotein dissociation and 
increase RNA purity. 
 
12. Centrifuge the tubes at a minimum of 12,000 x g for 5 minutes at 4ºC. Samples 
containing large amounts of cellular mucopolysaccharides can be re-extracted with 
chloroform (isoamyl alcohol may be included with the chloroform [CHCl3:IAA, 24:1, 
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v:v]) to increase RNA purity. Alternatively, a lithium chloride precipitation may be 
used (see the Troubleshooting section and references 3, 4). 
 
13. Transfer the upper phase to a new microcentrifuge tube without disturbing the 
interphase. If a portion of the interphase is transferred, repeat the centrifugation with 
the upper phase, and transfer the new upper phase to a clean microcentrifuge tube. 
 
14. Add 500 μl of cold absolute ethanol to the sample, invert 5X to mix and store at -
20ºC for at least 30 minutes. 
 
15. Centrifuge at a minimum of 12,000 x g for 15 minutes at 4ºC and remove the 
supernatant. The RNA will appear as a white pellet in the tube. If the pellet is floating 
the sample may be recentrifuged to place the pellet at the tube bottom. 
 
16. Wash the pellet with 500 μl of cold 75% ethanol (made with DEPC-H2O). 
 
17. Remove the ethanol, air dry 5 minutes at room temperature (DO NOT completely 
dry the RNA) and resuspend the RNA in 100 μl of DEPC-H2O for short-term storage. 
RNA is generally stable for up to a year at -80ºC. For longer term storage RNA 
samples may be stored at -20ºC as ethanol precipitates. When stored as an ethanol 
precipitate, the RNA must be precipitated and resuspended in aqueous solution prior 
to use. NOTE: RNA does not evenly distribute in ethanol and can lead to inconsistent 
RNA amounts between samples when equal volumes are pipetted. Vortex the 
RNA:ethanol solution to disperse the RNA prior to removing the sample. In situations 
where precise amounts of RNA are required it is best to precipitate the total amount 
(or excess) of RNA required, resuspend the RNA in DEPC-H2O and measure the 
concentration by OD260 before proceeding. 
 





















Appendix II: Protocols for microarray 
 




















































Appendix III: Ct-values from Real-Time experiments 
(See section 2.43, 2.44 and 3.4 for details) 
 
gap, gyceraldehyd-3-posphate dehydrogenase 
 
Table III – 1 Ct-values for calculation of the amplification efficient of gap. The 10-1 dilutions was used 
for calculation of expression. 





















-1 14.04 -1 13.42 -1 13.99 -1 13.62 -1 13.91 
-1.5 15.77 -1.5 15.22 -1.5 15.08 -1.5 15.45 -1.5 15.58 
-2 17.09 -2 17.48 -2 16.70 -2 16.96 -2 17.01 
-2.5 18.86 -2.5 18.89 -2.5 18.45 -2.5 18.69 -2.5 18.66 
-3 20.43 -3 20.78 -3 19.68 -3 20.3 -3 20.28 
          





















-1 14.13 -1 16.01 -1 13.68 -1 20.78 -1 14.89 
-1.5 15.82 -1.5 17.95 -1.5 15.70 -1.5 22.33 -1.5 16.64 
-2 17.21 -2 19.68 -2 17.12 -2 23.95 -2 18.18 
-2.5 19.15 -2.5 21.30 -2.5  -2.5 25.59 -2.5  




fbp, fibronectin binding protein 
 
Table III – 2 Ct-values for quantification of relative expression of intA. Shown are the Ct-values for 
the  10-1 dilutions for fbp and gap. The Ct-values used for calculation of the amplification efficiencies 
is specified in table VII-3 on next page. 
 Ct-value 
 fbp gap 
A0 19.72 13.73 
A30 19.65 14.01 
B0 19.93 13.61 
B30 19.01 13.50 
C0 19.92 11.97 
C30 20.63 13.51 
D0 23.96 17.00 





Table III – 3 Ct-values for calculation of the amplification efficient of fbp. 
 A0 A30 C0 C30 D0 D30 
-1 19.72 19.65 19.92 20.63 23.96 20.04
-1.5 21.33 21.54  22.28 25.75 22.25
-2 23.23 23.17 23.09  27.13 23.79
-2.5 24.74 24.81 25.27 25.43  25.09






intA, internalin A 
 
Table III – 4 Ct-values for quantification of relative expression of intA. Shown are the Ct-values for 
the  10-1 dilutions for intA and gap. The Ct-values used for calculation of the amplification efficiencies 
is specified in table VII-5 below. 
 Ct-value 
 intA gap 
A0 18.88 12.01 
A30 22.01 13.11 
B0 20.01 12.96 
B30 22.45 12.96 
C0 20.78 13.52 
C30 24.42 13.70 
D0 24.21 18.09 
D30 22.55 14.22 
 
Table III – 5 Ct-values for calculation of the amplification efficient of intA 
 A0 B0 B30 C0 C30 D0 
-1 18.88 22.65 22.45 20.74 24.46 26.96 
-1.5 20.65 24.25 24.16 22.46  28.56 
-2 22.11 25.71 25.83 23.69 27.8 30.2 
-2.5 23.8 27.79 27.59 25.46 29.84  
















intB, internalin A 
 
Table III – 6 Ct-values for quantification of relative expression of intB. Shown are the Ct-values for 
the  10-1 dilutions for intB and gap. Replicate 1 and 3 are performed on the same RNA, while replicate 
2 is a biological replicate. The expression for A5 and A20 are calculated against a mean of the Ct-
vaules for A0 intB and gap, while the other are calculated against the A0 values in the same replicate. 
The Ct-values used for calculation of the amplification efficiencies are specified in table VII-3 below. 
 Replicate 1 Replicate 2 Replicate 3  Replicate 1 
 Ct-value Ct-value Ct-value  Ct-value 
 intB gap intB gap intB gap  intB gap 
A0 19.23 12.23 19.4347 12.97 17.98 12.47 A5 19.93 14.55 
A30 21.33 13.02 21.65 13.95 23.02 15.44 A20 21.88 14.86 
B0 19.52 12.22 19.3 13.32      
B30 21.80 12.11 22.26 13.18      
C0 18.07 11.23 18.72 13.02 19.01 12.77 C5 19.74 14.05 
C30 23.58 12.69 24.033 13.17 25.33 14.69 C20 22.2 14.17 
D0 23.02 18.28 22.28 17.59      
D30 22.02 13.26 21.53 13.73      
 
  
Table III – 7 Ct-values for calculation of the amplification efficient of intB 
Dilution 
- log 10 
A30 D0 A30 B30 C0 
-1 21.33 23.02 21.65 21.74 18.72 
-1.5 22.88 24.93 23.12 23.43 20.07 
-2 24.45 26.75 24.53 24.72 21.95 
-2.5   26.62 26.1  
-3 27.79 29.86 28.01 27.78 25.49 
      
Dilution 
- log 10 
D0 D30 A20  C5  
-1 22.28 21.53 21.88 19.74  
-1.5 23.65 22.83 23.51 21.16  
-2 25.07 24.7 24.76 23.06  
-2.5  25.95 26.89 24.6  
-3 28.5 27.96 28.14 26.48  
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Appendix IV: Results from the microarray experiments (See section 2.5 and 3.5 for details) 
Table IV The complete list of microarray results. The A30, B30, and C30 samples were each hybridized against the A0 sample. The gene name, gene numbers, log2 
ratios and the P-values are listed.  
  A30/A0 B30/A0 C30/A0 







Transciptional regulators      
BC3095 Transcriptional regulator AnsR   -1.76 <0.005   
BC3826 Transcriptional regulator CodY     -0.59 0.037 
BC4703 Transcriptional regulator. DeoR family   3.03 0.006 1.10 0.037 
BC0518 Transcriptional regulator. Fur family -0.17 0.039 0.97 0.017   
BC3792 Transcriptional regulator. GntR family     1.32 0.034 
BC4603 Transcriptional regulator. GntR family 1.11 0.009   1.17 0.034 
BC3069 Transcriptional regulator. IclR family     0.92 0.038 
BC0657 Transcriptional regulator. MarR family   2.61 0.011 2.91 0.046 
BC4081 Transcriptional regulator. MarR family   -0.75 0.006   
BC1449 Transcriptional regulator. putative   2.39 <0.005   
BC2340 Transcriptional regulator. TetR family   2.73 0.049   
BC0961 Transcriptional regulator. TetR-related family     1.27 0.034 
BC3706 Transcriptional repressor GlnR   -1.57 0.049 -1.48(2) 0.042(2) 
BC4672 Catabolite control protein A 0.98 0.015   1.00 0.034 
        
Toxins      
BC3104 Hemolysin BL lytic component L2   -2.31 <0.005   
       
Stress response       
BC4312 Chaperone protein dnaK 0.89 <0.005 1.38 <0.005  1.17(2) 0.016(2) 
BC0294 Chaperonin. 10 kDa 1.29 <0.005 3.40 <0.005  2.16(2) 0.015(2) 
BC0295 Chaperonin. 60 kDa 0.78 <0.005 2.97 <0.005   
BC3539 Cold shock protein CspB   1.85 <0.005   
BC5152 ATP-dependent Clp protease. proteolytic subunit ClpP     1.51 0.037 
BC2214 Heat shock protein. Hsp20 family   3.33 0.047   
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Stress response continued        
BC4314 Heat-inducible transcription repressor HrcA     1.89 0.037 
BC4272 Superoxide dismutase. Mn   0.68 0.007   
BC0102 Negative regulator of genetic competence ClpC/MecB   2.48 0.047 1.80 0.039 
BC0443 Tellurium resistance protein   2.43 0.007 1.29 0.037 
BC0442 Tellurium resistance protein. putative   2.33 0.047 1.12 0.034 
BC0445 Tellurium resistance protein. putative   1.54 <0.005   
BC5398 Uracil-DNA glycosylase   1.03 0.006   
        
Motility        
BC1665 Flagellar biosynthetic protein FliP. putative -1.85 0.024     
BC1638 Flagellar hook-associated protein 2 -1.11 <0.005 -1.23 <0.005   
BC1645 Flagellar motor switch protein FliG     -0.82 0.036 
BC1662 Flagellar motor switch protein fliM   -0.71 0.048   
BC0576 Methyl-accepting chemotaxis protein   -0.99 0.008   
        
Membrane-/cell wall-associated       
BC3791  Lipoprotein. Bmp family   1.43 0.027   
BC5242 Membrane protein with C2C2 zinc finger     -1.31 0.034 
BC1227 Membrane protein. putative   0.68 0.006   
BC2152 Membrane protein. putative     -0.67 0.037 
BC3542 Membrane protein. putative     -0.78 0.036 
BC3709 Membrane protein. putative   -0.74 0.009   
BC0991 S-layer protein. putative 0.41 0.036 -1.48 <0.005   
BC4549 LPXTG-motif cell wall anchor domain protein. putative     -1.45 0.034 
BC1331 Internalin. putative   -0.58 0.097   
BC4927 Cell surface protein   -1.05 <0.005   
        
Sporulation        
BC4435 sporulation initiation phosphotransferase. putative     -0.78 0.037 
BC5327 stage II sporulation protein R. putative     -0.81 0.039 
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Sporulation continued        
BC0053 stage V sporulation protein G   1.10 0.036   
BC1612 germination protein gerN   1.98 0.010   
        
Cell division/DNA replication       
BC5475 Single-stranded DNA-binding protein    -0.94 0.037 
BC1461 Site-specific recombinase. phage integrase family   3.53 0.049   
BCp0005 Type B DNA polymerase 1.53 <0.005 1.72 <0.005 1.22 0.034 
BC4649 Septation ring formation regulator   -0.77 0.005   
BC4443 Septum site-determining protein MinC -0.35(1) 0.035(1) 0.65 0.009   
BC0001 Chromosomal replication initiator protein DnaA   -0.79 0.041   
BC0072 Cell division protein FtsH     0.75 0.037 
        
Transport        
BC0160 ABC transporter. ATP-binding protein   -0.82 0.033   
BC4743 ABC transporter. ATP-binding protein     -0.88 0.037 
BC0873 Amino acid ABC transporter. permease protein     -1.26 0.038 
BC0865 Amino acid permease family protein     -2.25 0.037 
BC3463 Arsenical pump family protein   1.20 0.040   
BC0962 Drug resistance transporter. EmrB/QacA family     2.80 0.034 
BC4000 Drug resistance transporter. EmrB/QacA family   2.76 <0.005   
BC4568 Drug resistance transporter. EmrB/QacA family   3.35 0.042   
BC0381 Iron compound ABC transporter. permease protein     -0.88 0.047 
BC5104 Iron compound ABC transporter. permease protein   -1.20 0.007 -0.68 0.037 
BC5105 Iron compound ABC transporter. permease protein       
BC5012 Major facilitator family transporter     -0.91 0.034 
BC1948 Hypothetical Multidrug-Efflux Transporter     -0.76 0.044 
BC0596 Heavy metal-transporting ATPase   1.68 <0.005   
BC1182 Oligopeptide ABC transporter. ATP-binding protein     1.40 0.046 
BC0907 Oligopeptide ABC transporter. oligopeptide-binding protein     -1.16 0.037 
BC1180 Oligopeptide ABC transporter. permease protein     1.47 0.037 
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Transport continued        
BC1181 Oligopeptide ABC transporter. permease protein   1.87 <0.005   
BC1432 Proton/glutamate symporter family protein   1.01 0.009   
BC2170 Sodium-dependent transporter. putative     0.88 0.034 
BC4121 Na+/H+ antiporter NhaC   1.49 0.005   
BC5435 Transporter. AcrB/AcrD/AcrF family     -0.63 0.037 
BC0318 Transporter. Drug/Metabolite Exporter family   -0.83 <0.005   
BC4544 Ferrichrome transport ATP-binding protein fhuC     -1.32 0.037 
BC0631 PTS system. trehalose-specific IIBC component     1.60 0.039 
BC3890 Uracil permease     1.32 0.034 
BC0297 Xanthine/uracil permease family protein   0.87 <0.005   
BC5395 Xanthine/uracil permease family protein   -1.01 0.009 -0.71 0.039 
BC1836 Branched-chain amino acid transport system carrier protein   2.48 <0.005   
BC4895 SapB protein   1.08 0.045   
BC3355 CBS domain protein   1.65 0.042   
BC4507 Aquaporin Z   -1.22 <0.005   
        
Translation        
BC0124 Ribosomal protein L7A family 0.74 <0.005 -0.96 0.040 -0.63(2) 0.014(2) 
BC0125 Ribosomal protein S12   -0.69 0.022   
BC0130 Ribosomal protein S10   -0.61 0.020   
BC0134 Ribosomal protein L2   -0.68 0.030   
BC0135 SSU ribosomal protein S19P     -0.59 0.039 
BC0137 Ribosomal protein S3   -0.75 0.039   
BC0143 Ribosomal protein L5   -0.64 0.021   
BC0155 Ribosomal protein L36   -1.01 <0.005   
BC4436 Ribosomal protein L27 0.56 <0.005 0.95 <0.005   
BC4263 Ribosomal protein L33 0.22 0.016 0.75 0.010   
BC4320 Ribosomal protein S20     0.64 0.039 
BC5075 LSU ribosomal protein L11P   1.21 0.047   
BC5062 Tyrosyl-tRNA synthetase   1.01 <0.005   
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Translation continued         
BC0154 Translation initiation factor IF-1   -1.26 0.013   
        
Metabolism         
Fermentation, TCA and oxidative phosphorylation       
BC3372 6-phosphogluconate dehydrogenase family protein     0.95 0.037 
BC4600 Phosphofructokinase     0.59 0.039 
BC5135 Enolase -0.33 0.430     
BC0632 Trehalose-6-phosphate hydrolase     1.23 0.042 
BC3972 Pyruvate dehydrogenase complex E1 component. beta subunit     0.75 0.038 
BC3971 Pyruvate dhg complex E2 - dihydrolipoamide acetyltransferase   -1.00 <0.005   
BC3970 Pyruvate dhg complex E3 - dihydrolipoamide dehydrogenase -0.74(1) 0.239(1) 0.28 <0.005 0.70 0.094 
BC3774 Pyruvate ferredoxin oxidoreductase. alpha subunit. putative   0.63 0.022   
BC4160 Dihydrolipoamide dehydrogenase      2.34(2) 0.029(2) 
BC0868 Glyceraldehyde-3-phosphate dehydrogenase. NADP-dependent   1.04 0.036   
BC5335 Fructose-bisphosphate aldolase. class II -0.58(1) 0.0311(1) 1.25 <0.005   
BC5002 Acyl-CoA dehydrogenase   1.02 0.020   
BC4594 Citrate synthase CitZ   1.52 <0.005   
BC4517 Succinate dehydrogenase. flavoprotein subunit 1.23 <0.005 1.98 <0.005 1.64 0.039 
BC4516 Succinate dehydrogenase. iron-sulfur protein   1.33 <0.005 1.31 0.034 
BC4592 Malate dehydrogenase   2.71 0.042 1.39 0.039 
BC4593 Isocitrate dehydrogenase. NADP-dependent   2.90 0.038   
BC0665 Transaldolase. putative   0.92 <0.005   
BC3885 Dihydroorotate dehydrogenase. electron transfer subunit   -2.45 <0.005   
BC1939 Cytochrome d ubiquinol oxidase subunit II     -1.40 0.034 
BC4792 Cytochrome d ubiquinol oxidase. subunit I   -0.65 0.014   
BC5294 NADH-quinone oxidoreductase chain K   -0.74 0.011   
BC5306 ATP synthase F1. beta subunit 0.31 <0.005 -0.62 <0.005   
BC5307 ATP synthase F1. gamma subunit   -1.19 <0.005   
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Metabolism       
Proteins, peptides, and amino acids.       
BC1120 CAAX amino terminal protease family protein   3.13 0.047   
BC0293 CAAX amino terminal protease family protein  0.47(1) 0.031(1) 1.98 <0.005   
BC0360 Aminopeptidase AmpS   0.78 0.031   
BC4678 Aminopeptidase. putative   1.53 0.007   
BC4198 Proline dipeptidase -0.25 0.034 -0.88 0.049   
BC4614 Proline dipeptidase     0.72 0.039 
BC4693 Peptidase. M42 family   0.70 0.011   
BC4377 Peptidase. U32 family -0.85(1) 0.048(1) -1.79 0.006 -0.59 0.037 
BC0289 O-sialoglycoprotein endopeptidase     0.59 0.038 
BC1338 Oligoendopeptidase F. putative   1.12 0.006   
BC1233 p-aminobenzoate synthase glutamine amidotransferase. comp. II   1.82 0.008   
BC0153 Methionine aminopeptidase -0.32 <0.005 -1.10 <0.005   
BC3962 Lysine decarboxylase   0.94 0.027   
BC4135 L-serine dehydratase. iron-sulfur-dependent. alpha subunit   -0.60 0.008   
BC3094 L-asparaginase   -1.68 <0.005   
BC4162 Leucine dehydrogenase 0.77 0.030 1.62 <0.005 -2.42(2) 0.015(2) 
BC4224 Glycine cleavage system P protein. subunit 2   1.38 0.012 1.36 0.034 
BC4225 Glycine cleavage system P-protein. subunit 1   1.79 <0.005 1.85 0.034 
BC4226 Glycine cleavage system T protein   1.58 <0.005   
BC2439 Aminoacyl-histidine dipeptidase     0.95 0.040 
BC3889 Aspartate carbamoyltransferase     1.25 0.034 
BC1746 Aspartate--ammonia ligase   1.09 <0.005   
BC1491 Glutamate dehydrogenase   0.70 0.007   
BC2942 Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase   2.46 0.009   
BC3887 Carbamoyl-phosphate synthase. small subunit -1.32 0.008 -1.44 0.005   
BC1234 Anthranilate phosphoribosyltransferase   2.16 0.020   
BC2241 Aldehyde dehydrogenase family protein   1.78 0.014   
BC4003 5-met-tet-hydropteroyltriglutamate-cysteine methyltransferase   2.90 0.018   
BC4159 3-methyl-2-oxobutanoate dehydrogenase. alpha subunit      1.94(2) 0.031(2) 
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Peptidoglycan-metabolism       
BC0677 Undecaprenol kinase family protein  0.59 0.017   
BC5334 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2   0.71 0.006   
BC3912 UDP-N-acetylmuramoylalanine--D-glutamate ligase     -0.61 0.037 
BC3913 Phospho-N-acetylmuramoyl-pentapeptide-transferase   -0.70 0.023   
BC5278 Chain length regulator (capsular polysaccharide biosynthesis)   -2.13 0.036   
BC1974 Polysaccharide deacetylase. putative   -0.77 0.009   
        
Metabolism        
Other metabolitic genes        
BC4938 Pyridine nucleotide-disulphide oxidoreductase     1.05 0.044 
BC0013 Inosine-5'-monophosphate dehydrogenase -0.24 0.050   0.90 0.034 
BC0697 Quinol oxidase. subunit I -0.74 <0.005 -0.68 <0.005   
BC1290 Phosphatidylglycerophosphatase B     -0.93 0.034 
BC3882 Orotate phosphoribosyltransferase -2.31 0.011     
BC1353 NrdI protein   -1.07 <0.005   
BC4045 Nitroreductase family protein   0.85 0.019   
BC4329 Nicotinate (nicotinamide) nucleotide adenylyltransferase   -0.72 0.007   
BC4853 Naphthoate synthase   0.89 0.011 -1.13(2) 0.014(2) 
BC4856 Menaquinone-specific isochorismate synthase     0.63 0.037 
BC0071 Hypoxanthine phosphoribosyltransferase     0.79 0.038 
BC2101 Formate--tetrahydrofolate ligase     1.50 0.038 
BC0344 Delta-1-pyrroline-5-carboxylate dehydrogenase. putative   2.93 0.048 2.04 0.034 
BC0884 Alpha-acetolactate decarboxylase     1.03 0.034 
BC0668 Alcohol dehydrogenase. zinc-containing   2.37 <0.005   
BC0152 Adenylate kinase -0.12 <0.005 -1.09 0.009   
BC3616 Aconitate hydratase 1     1.60 0.041 
BC0883 Acetolactate synthase   2.81 0.047 1.64 0.034 
BC1173 3-oxoacyl-(acyl-carrier-protein) synthase III   -1.46 0.032   
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Metabolism Other metabolitic genes, continued       
BC1760 3-oxoacyl-(acyl-carrier-protein) synthase III. putative     0.79 0.037 
BC4111 3,4-dihydroxy-2-butanone 4-phosphate synthase   1.19 <0.005   
Other functions        
BC4521 Thioredoxin -0.82 0.019 1.24 <0.005   
BC1305 YkgG family protein   0.79 0.049   
BC2932 Sulfatase   2.29 <0.005   
BC5087 Putative lantibiotic precursor peptide   3.41 0.030   
BC5088 Putative lantibiotic precursor peptide   2.80 <0.005   
BC5090 Putative lantibiotic precursor peptide   2.90 <0.005   
BC1711 Short chain dehydrogenase     -0.70 0.037 
BC4393 Rrf2 family protein   -0.64 0.006   
BC4210 Rhodanese-like domain protein     -1.00 0.034 
BC1436 PspA/IM30 family protein   5.42 <0.005   
BC4270 Penicillin-binding protein   0.82 0.008   
BC2281 Penicillin-binding protein 1A   1.23 <0.005   
BC4492 Phosphoesterase. putative     -0.82 0.034 
BC3854 Phosphatase. putative     -0.86 0.034 
BC1316 PhaR protein   1.71 0.016   
BC4952 NifU domain protein     0.81 0.037 
BC1553 Multimodular transpeptidase-transglycosylase     -0.67 0.037 
BC4854 Hydrolase. alpha/beta fold family     0.63 0.038 
BC1165 Hydrolase. haloacid dehalogenase-like family   1.25 0.026   
BC5379 HD domain protein     -0.91 0.039 
BC3933 ComK regulator 0.58 0.013 0.67 0.011   
BC0303 Alpha/beta hydrolase   0.99 0.036   
BC4332 GTPase family protein   -0.75 0.037   
BC4161 Butyrate kinase     2.20 0.034 
BC0104 DNA-binding protein. putative   0.72 0.006   
BC1224 Acetyltransferase   2.48 0.049   
BC0587 Acetyltransferase. GNAT family   3.02 <0.005   
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Other functions continued         
BC1349 Acetyltransferase. GNAT family   0.65 0.013   
BC1368 2-nitropropane dioxygenase   0.60 0.006   
Hypotetical        
BCp0018 Hypothetical cytosolic protein   1.14 0.007 -0.67 0.047 
BCp0019 Hypothetical protein     -0.70 0.037 
BCp0001  Hypothetical protein 1.38 <0.005   -1.23(2) 0.032(2) 
BCp0002 Hypothetical protein 2.27 0.019 1.89 0.022 1.24 0.034 
BCp0004 Hypothetical cytosolic protein   1.77 0.030   
BC5388 Conserved hypothetical protein   0.63 0.017   
BC5326 Conserved hypothetical protein    -1.74 0.034 
BC0520 Conserved hypothetical protein 0.58 0.009 1.08 <0.005   
BC0687 Conserved hypothetical protein   0.91 0.007   
BC0880 Conserved hypothetical protein     -1.67(2) 0.014(2) 
BC1012 Conserved hypothetical protein   0.90 0.010   
BC1150 Conserved hypothetical protein   0.64 0.006   
BC1169 Conserved hypothetical protein   0.69 0.007   
BC1303 Conserved hypothetical protein   0.77 0.017   
BC1435 Conserved hypothetical protein   6.86 <0.005   
BC1528 Conserved hypothetical protein -0.16 0.048 1.20 <0.005   
BC1563 Conserved hypothetical protein   -0.64 0.006   
BC2841 Conserved hypothetical protein   1.94 0.027   
BC2969 Conserved hypothetical protein     -0.87 0.034 
BC3605 Conserved hypothetical protein   1.79 0.007   
BC3787 Conserved hypothetical protein   0.83 <0.005   
BC3844 Conserved hypothetical protein   -1.25 <0.005   
BC4182 Conserved hypothetical protein 0.22 0.039 -0.77 0.042   
BC4274 Conserved hypothetical protein   0.70 0.007   
BC4308 Conserved hypothetical protein     -0.74 0.037 
BC4382 Conserved hypothetical protein -0.59 <0.005 -0.69 0.006   
BC4519 Conserved hypothetical protein   1.13 0.009   
        
  139 
  A30/A0 B30/A0 C30/A0 







Hypotetical continued        
BC4531 Conserved hypothetical protein     -0.59 0.044 
BC4547 Conserved hypothetical protein   -0.82 0.006 -1.51 0.042 
BC4569 Conserved hypothetical protein   2.39 0.047   
BC4634 Conserved hypothetical protein     0.64 0.037 
BC4653 Conserved hypothetical protein   1.61 0.006   
BC4752 Conserved hypothetical protein   0.67 0.006   
BC5060 Conserved hypothetical protein     0.65 0.045 
BC5154 Conserved hypothetical protein     0.65 0.038 
BC5158 Conserved hypothetical protein     -0.84 0.037 
BC5208 Conserved hypothetical protein     -0.69 0.042 
BC5289 Conserved hypothetical protein   -1.07 <0.005   
BC4328 Conserved hypothetical protein TIGR00488     -0.59 0.037 
BC0248 Hypothetical protein   3.55 <0.005   
BC0250 Hypothetical protein   3.35 <0.005   
BC0739 Hypothetical protein   0.63 0.016   
BC2552 Hypothetical protein   -2.41 0.010 -1.00(2) 0.018(2) 
BC2842 Hypothetical protein   1.54 0.041   
BC5243 Hypothetical protein     -0.91 0.036 
        
Genes with bold BC-number are also investigated by real-time or 2-DE. (1) Genes in the A30/A0 hybridization that is only confirmed with one biological replicate. (2) 
Genes in the C30/A0 hybridization that is confirmed by two biological replicates. 
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Appendix V: 2-D electrophoresis gels of LiCl extracts from cultures in shift 
experiments (See section 2.6.3.2 and 3.6.4.1 for details) 
 
Figure A0 – 1: 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 
immediately after the shift. 
 
Figure A0 – 2: 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 
























Figure A0 – 3 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 
immediately after the shift. 
 
 
Figure A0 – synthetic: Synthetic 2-DE protein gel of LiCl extract of B. cereus harvested from the 

























Figure A30 – 1: 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 30 
minutes after the shift 
 
Figure A30 – 2: 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 30 

























Figure A30 – 3: 2-DE protein gel of LiCl extract of B. cereus harvested from the control culture 30 
minutes after the shift. 
 
Figure A30 – synthetic: Synthetic 2-DE protein gel of LiCl extract of B. cereus harvested from the 
























Figure B30 – 1: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile culture 30 
minutes after the shift. 
 
 
Figure B30 – 2: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile culture 30 
























Figure B30 – 3: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile culture 30 




Figure B30 – synthetic: Synthetic 2-DE protein gel of LiCl extract of B. cereus harvested from the 
























Figure C30 – 1: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile salts culture 30 
minutes after the shift. 
 
 
Figure C30 – 2: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile salts culture 30 
























Figure C30 – 3: 2-DE protein gel of LiCl extract of B. cereus harvested from the bile salts culture 30 
minutes after the shift. 
 
 
Figure C30 – synthetic: Synthetic 2-DE protein gel of LiCl extract of B. cereus harvested from the 
bile salts culture 30 minutes after the shift. The spot volumes are the average of C30 – 1, 2, and 3.   
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